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 ABSTRACT 
 This thesis addresses two studies, 1) characterization of a glutathione 
peroxidase 4 (GPx4) haploid insufficient (+/-) mouse and 2) effects of different 
levels of glutathione peroxidase 1 (GPx1) and Cu, Zn - superoxide dismutase 
1 (SOD1) gene dosage on enzyme expression and responses to paraquat 
(PQ), diquat (DQ) and/or acetaminophen (AP) toxicity. These studies are 
united in a general way by addressing response to oxidative stress with 
altered antioxidant enzyme expression and in a more specific way by 
involvement of two selenium (Se) containing glutathione peroxidases (GPx1 
and GPx4) and SOD1. All three of these enzymes are believed to be involved 
in in vivo metabolism of reactive oxygen species (ROS). 
 GPx4 is structurally and functionally unique among selenoperoxidases 
since it functions as a monomer and is able to metabolize phospholipid 
hydroperoxides. GPx4 is more resistant to Se depletion than other 
selenoperoxidases and deletion of both GPx4 alleles is embryonic lethal, 
indicating an important role that is not yet fully understood. 
 Experiment 1 examined the effects of deletion of one gpx4 allele at 
baseline and with a ROS challenge. GPx4+/- and wild-type (WT or GPx4+/+) 
mice were injected with 24 mg/kg body weight of the ROS generator PQ or 
phosphate buffered saline (PBS) control and sacrificed 4 h later. GPx4+/- mice 
had decreased GPx4 activity in lung, liver, kidney and testis, from 24 to 39% 
(P <  0.05) lower activity than WT. GPx4+/- mice had a 34% (P <  0.05) 
decrease in testis Se concentration. GPx4+/- had no effect on Se 
concentration, protein carbonyl formation (measure of oxidized protein) or 
GPx1 activity in other tissues or GPx3 and alanine aminotransferase (ALT) 
activity in plasma. In summary, deletion of one gpx4 allele demonstrated a 
range of effects on GPx4 activities and Se concentrations, but did not affect 
 
 susceptibilities to pro-oxidant-induced protein oxidation in various tissues of 
mice.  
 SOD1 and GPx1 are often considered to detoxify ROS in the cytosol. 
SOD1 produces hydrogen peroxide from superoxide which GPx1 reduces to 
water. A dramatic increase in ROS lethality has been found in cells and mice 
lacking GPx1 or SOD1 (GPx1-/- or SOD1-/-) whereas GPx1-/- hepatocytes are 
protected against reactive nitrogen species (RNS) induced cell death.  
 Experiment 2 compared responses of mice with various gene dosages 
of both SOD1 and GPx1 in a 72 h survival trial to the ROS generator DQ (25 
mg/kg body weight) or the putative in vivo RNS generator AP (600 mg/kg body 
weight). Although this experiment was limited by sample size and group death 
rates, some general trends emerged. The SOD1 knockout allele decreased 
AP-induced mortality and increased DQ-induced mortality (P <  0.05). The 
GPx1 knockout allele increased mortality from both AP and DQ (P <  0.05). In 
combination, mice with only one functional copy in total of SOD1 and GPx1 
(GPx1+/-|SOD1-/- or GPx1-/-|SOD1+/-) had significantly decreased DQ 
survival time but unchanged AP survival time (P <  0.05). AP-treated GPx1+/-
|SOD1+/+ mice died significantly earlier than control (<40 h) but GPx1+/-
|SOD1+/- survival time was not significantly different from control (>72 h). 
SOD1 knockout was also associated with 28 to 34% decreases in GPx1 
activity, (P <  0.05; +/+ vs. +/- and P = 0.078 +/+ vs. -/-), depending on SOD1 
copy number). Plasma ALT peaked between 20-40 h (11740 ± 1074) with AP 
treatment and <20 h with DQ treatment (2129 ± 537) but was unchanged in all 
surviving mice. 
 In summary, there are a variety of responses to antioxidant enzyme 
knockouts and not all are detrimental to defense against oxidative stress. In 
Experiment 1, gpx4 deletion reduced tissue GPx4 activity and testis Se without 
 
 increased susceptibility to PQ toxicity. In Experiment 2, SOD1 knockout was 
associated with high resistance to AP toxicity, high susceptibility to DQ toxicity 
and decreased GPx1 activity while GPx1 knockout was associated with 
increased AP and DQ mortality. Overall, the effect of SOD1 knockout on 
resistance to AP lethality was greater than the effect of GPx1 knockout on AP 
lethality. 
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CHAPTER 1: 
LITERATURE REVIEW 
Introduction 
In the process of normal aerobic metabolism, reactive oxygen species 
(ROS) are formed. Enzymatic systems are a very important means by which 
cells can maintain these potentially damaging molecules within concentrations 
needed for normal cellular function. At normal concentrations, ROS such as 
superoxide, hydrogen peroxide and lipid hydroperoxides are able to regulate 
activities of kinases, transcription factors and apoptotic factors in addition to 
contributing to the normal function of many other metabolic and signaling 
systems. Chronically increased levels of ROS can contribute to pathological 
states including cancer and cardiovascular disease (Finkel, 1998; Rhee, 1999; 
Thannickal and Fanburg, 2000; Nomura et al., 2001) while acute increases in 
ROS can lead to massive damage of biomolecules (e.g. protein, DNA and 
lipids) and consumption of reducing molecules (e.g. NADPH) leading to 
cellular apoptosis or necrosis and, on a whole animal scale, death (Bus et al., 
1974; Smith, 1977; Witschi et al., 1977; Cagen and Gibson, 1977; Keeling and 
Smith, 1982; Burk, 1991; Sunde, 1994; Ho et al., 1997; Berlett and Stadtman, 
1997; Cheng et al., 1998; De Haan et al., 1998; Cheng et al., 1999). 
Selenium-dependent glutathione peroxidases 1 and 4 and copper, zinc-
dependent superoxide dismutase 1 are three important micronutrient 
dependent enzymes in coping with oxidative stress (McCord and Fridovich, 
1969; Flohe et al., 1973; Rotruck et al., 1973). 
  
Selenium 
Although the first report of Se in mammalian tissue was in 1916 
(Gassmann, 1916), this finding was considered to be an artifact (See: Gmelins 
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Handbuch der Anorganischen Chemie, Selen, Vol. 1, Part A, p. 24., 1953)  
and Se was understood to be toxic. Many years passed before Se was finally 
recognized as an essential nutrient in bacteria by Pinsent et al., (1954) and in 
rats by Schwartz and Foltz (1957). This delay in the discovery of Se as a 
nutrient is in part due, as later work showed, to the ability Se and vitamin E to 
spare one another’s requirement for prevention of some signs of deficiency 
(Thompson and Scott, 1969; Scott, 1980). Careful observation showed that 
some of these symptoms responded specifically to one or the other of these 
nutrients (Harris et al., 1958). 
An example of the importance of selenium in the human diet, Keshan 
disease, an endemic juvenile onset cardiomyopathy, has been traced to the 
low soil selenium content in a region of China, leading to low Se intake and 
association with low body Se content (Keshan disease research group, 
1979a). A study of Se supplementation followed these discoveries which 
showed that it helped to prevent the disease (Keshan disease research group, 
1979b). Another interesting feature of Keshan disease is that it cannot be 
explained by Se deficiency alone. The cardiomyopathy has been associated 
with the virus Coxsackie B4, which mutates under conditions of low Se to 
become pathogenic (Levander and Beck, 1997). Among other species, Se 
deficiency is associated with a number of different symptoms. In rats, Se 
deficiency is associated with sparse hair coat, poor growth, poor sperm motility 
and cataracts (see Levander et al., 1995 for review). In ruminants, Se 
deficiency can cause white muscle disease (a nutritional muscular dystrophy) 
(Muth et al., 1958), dystrophic tongue, heart failure and retained placenta. Se 
deficiency is associated with reduced serum selenium, increased AST activity 
and white muscle disease in horses. Deficiencies of Se and vitamin E can 
cause sudden death of young, rapidly growing pigs and a deficiency of 
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selenium in growing chickens causes exudative diathesis (a weeping edema 
of the skin with easy bruising) (see The Merck Veterinary Manual, Eighth 
Edition [2003] for review). 
 
Selenoproteins 
The vast majority of mammalian selenoproteins incorporate Se in the 
form of the 21st amino acid, selenocysteine (Bock, 2001; Hatfield and 
Gladyshev, 2002). In many cases, selenium is present at a catalytic center of 
an enzyme responsible for redox reactions (Stadtman, 2000; 2001). In 
selenoprotein mRNA, the stop codon UGA encodes SeCys insertion, requiring 
a specialized group of transcription factors to translate it properly (see Berry et 
al. 2001 and Copeland, 2003 for review). The process of SeCys incorporation 
is highly selenium dependent, requiring both cis and trans acting components 
that lead to a hierarchy of Se-protein expression (Allan et al., 1996; Sunde, 
2001). Se deficiency often results in a lack of selenoprotein expression 
through altered mRNA stability and protein translation (Chu et al., 1990; Allan 
et al., 1999).  
Selenocysteine incorporation requires a SeCys charged tRNA 
containing the UCA codon (Diamond et al., 1981; Leinfelder et al., 1988). The 
SeCys tRNA has methylated and non-methylated isoforms, indicating a 
possible mechanism for mediating the hierarchy of Se incorporation into 
protein (Jameson and Diamond, 2004)   
 Although the eukaryotic synthesis of SeCys tRNA is not yet fully 
characterized, a partial picture of the process has emerged. Selenocysteine is 
synthesized on a tRNA initially charged with serine (Carlson et al., 2001), 
which is phosphorylated to form a phosphoseryl tRNA. An activated selenium 
group (most likely monoselenophosphate, formed by a selenophosphate 
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synthetase) is then exchanged for the phosphate group, completing the 
synthesis of SeCys tRNA (see Review by Hatfield and Gladyshev, 2002).   
 In order to incorporate SeCys at the UGA codon, a cis-acting 
selenocysteine insertion sequence (SECIS) is located in the 3’ untranslated 
region (3’UTR) of the mRNA (Berry et al., 1991). The sequence of SECIS is 
not highly conserved among eukaryotes but they are structurally similar across 
species, forming a stem-loop (Martin and Berry, 2001). The SECIS binding 
protein 2 (SBP2) which has been shown to bind with SECIS, is able to interact 
with ribosomes (Copeland et al., 2001). It is believed that these characteristics 
allow SBP2 to alter the ribosomes reading of the genetic code such that UGA 
leads to SeCys incorporation (Copeland et al., 2001). 
A recent paper by Kryukov et al., (2003) reported 25 distinct putative 
selenoproteins, identified by a computer algorithm based on the presence of 
the SeCys codon and a SECIS element. Although not all of these may be 
active genes, it is exciting to consider these potential subjects of selenoprotein 
research next to the known and characterized selenoproteins (n=14, based on 
Lei, 2001). 
 Among the well characterized selenoproteins (Burk and Hill, 1993; 
Sunde, 1994; Stadtman, 1996; Flohe et al., 1997), the glutathione peroxidases 
form the largest single family. Included in this group are cellular or classical 
glutathione peroxidase (GPx1), gastrointestinal or GI glutathione peroxidase 
(GPx2), plasma or extracellular glutathione peroxidase (GPx3) and 
phospholipid hydroperoxide glutathione peroxidase (GPx4). The recently 
discovered glutathione peroxidase 6 is present in adult olfactory epithelium, 
however, while the human isoform does contain selenium, the isoform found in 
mouse does not. The iodothyronine deiodinases, types 1, 2 and 3 (ID1, ID2 
and ID3) regulate thyroid hormones by catalyzing their deiodination (Berry et 
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al., 1991; Croteau et al., 1996; Salvatore et al., 1995). Another group of 
selenoproteins with antioxidant functionality are the thioredoxin reductases 
which reduce the thiol containing small protein thioredoxin (Tamura and 
Stadtman, 1996; Gromer et al., 1998; Sun et al., 1999). The ATP dependent 
activation of selenium during selenocysteine synthesis is catalyzed by the 
selenoprotein Selenophosphate synthetase (Kim et al., 1997). Accounting for 
approximately 65% of plasma selenium, Selenoprotein P (Sel P) also has 
some antioxidant properties but its role is still unclear (Saito et al., 1999). 
Containing 10 SeCys residues, Sel P is also the only known selenoprotein to 
contain more than one SeCys residue (Hill et al., 1991). It has also been found 
to have multiple isoforms forms in the rat (Himeno et al., 1996; Chittum et al., 
1996). Selenoprotein W (Sel W) is a small (10kDa) selenoprotein expressed in 
all tissues. The physiological role of Sel W is still unknown but it may be 
related to white muscle disease (a disease of Se deficiency) in animals 
(Vendeland et al., 1993; 1995). A third selenoprotein whose role is as yet 
unknown is the 15kDa selenoprotein (15-kD Sel) which was discovered in 
human T cells and is expressed ubiquitously (Gladyshev et al., 1998). 
 
Glutathione and the Glutathione Peroxidases 
 The selenium dependent glutathione peroxidases share certain 
characteristics, including the presence of a single SeCys residue per monomer 
and the ability to reduce peroxides using glutathione (GSH) as a cofactor, 
producing a cognate alcohol and glutathione disulfide (GSSG). Substrate 
specificity varies among the Se-GPx family; for example, only GPx4 is able to 
efficiently reduce phospholipid hydroperoxides. There is also structural 
variation among these proteins with GPx1, 2 and 3 functioning as tetramers of 
approximately 90kDa while GPx4 functions as a monomer of approximately 20 
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kDa . Expression patterns also distinguish the glutathione peroxidases. GPx1 
is expressed ubiquitously but is especially high in the liver and kidney. GPx2 
expression is primarily in the gastrointestinal tract and GPx3 is expressed 
extracellularly as a glycoprotein. The expression of GPx4 is also ubiquitous 
but expression is particularly high in the testes (see Lei, 2001 for review). 
 
Glutathione 
 Glutathione is a thiol containing tripeptide (Glu-Cys-Gly) which serves 
as a cofactor for the glutathione peroxidases. Glutathione and other low 
molecular weight thiols have the advantage in redox reactions of being easily 
oxidized and regenerated. Due to these characteristics, glutathione can play 
an essential role in many biochemical and pharmacological reactions (Mates, 
2000; Locigno and Castronovo, 2001; Paolicchi et al., 2002).  Some of the 
important roles of glutathione are: reduction or inactivation of ROS and RNS 
by formation of glutathione disulfide (GSSG) and conjugation of reduced 
glutathione (GSH) with a xenobiotic and subsequent elimination as a 
mercapturic acid (Berlett and Stadtman, 1997; Hayes et al., 1999; Strange et 
al., 2001).  The functions of the glutathione system in redox balance and in 
xenobiotic detoxification demonstrate the importance of understanding this 
system in a physiological context and make it an interesting potential target for 
genetic and therapeutic manipulation. 
 
Glutathione Peroxidase 1 
 Glutathione Peroxidase 1 (EC: 1.11.1.9, GPx1), also known as cellular 
or “classic” glutathione peroxidase was the first identified mammalian 
selenoprotein (Rotruck et al., 1972) in a report of hydrogen peroxide 
dependent hemolysis which was not prevented by glucose in Se deficient rats. 
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This discovery was foreshadowed by the work of Mills (1957) and Schwarz 
and Folz (1957) who discovered GPx protection of hemoglobin against 
oxidation and the essentiality of Se in preventing rat liver necrosis. 
Additionally, Mills et al., (1959, 1960) identified GPx1 as a distinct peroxidase 
from others already known since its activity could not be inhibited by azide or 
cyanide.  
 Flohe et al., (1972) identified GPx1 as a 23 kDa protein containing one 
Se atom which functions as a homotetramer of 88 kDa. In the mouse, the 
GPX1 gene is 5.2 kb in length with two exons and one intron (Chambers et al., 
1986; Ho et al.,1997). Mammalian GPx1 proteins are approximately 201 
amino acids in length with a selenocysteine at position 47 (Sunde, 1994). Most 
GPx1 activity (75%) is found in the cytosol with the remaining 25% of activity 
in the mitochondria (Flohe, 1989).  Although GPx1 activity is expressed in 
most tissues of rodents, the liver and kidney have the highest levels of activity 
(Lei et al., 1995; Bermano et al., 1995; Cheng et al., 1998).  
 Expression of GPx1 varies widely and in rapid fashion to changes in 
bodily Se status (Cheng et al., 1997). These Se dependent expression 
patterns show a range of effect among the Se- glutathione peroxidases. For 
example, by 130 days of Se depletion, mouse liver GPx1 activity falls to near 
zero while 40% of GPx4 activity remains (Weitzel et al., 1990). Activity and 
mRNA follow the same pattern in rats with 1 and 6% of Se adequate levels 
remaining, respectively while liver GPx4 activity is reduced to about 40% and 
mRNA levels are nearly unchanged (Lei et al., 1995). 
For some time, the in vivo role of GPx1 was unclear. Although studies in 
cells supported the function of GPx1 in protecting against ROS (Mirault et al., 
1991; Geiger et al., 1993) there was disagreement about whether GPx1 filled 
the same role in vivo (Burk et al., 1980; Mercurio and Combs, 1986a; 1986b; 
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Burk et al., 1995). Based on its response to Se deficiency relative to other Se 
proteins, a major alternative hypothesis to GPx1 as an antioxidant is a role in 
Se homeostasis (Burk, 1991; Sunde, 1994). In support of this, the GPx1 
knockout mouse appeared to have no phenotypic defects and showed no 
increased sensitivity to hyperoxia (Ho et al., 1997).  However, work by Cheng 
et al., (1997) found that GPx1 knockout in mice had no effect on other 
selenoperoxidases (e.g. GPx3, GPx4) under conditions of Se adequacy and 
depletion, indicating that GPx1 was not acting as a buffer of bodily Se. More 
convincingly, Cheng et al., (1998) used the GPx1 knockout mouse model to 
show that GPx1 mediated selenium’s protection against acute oxidative stress. 
Based on this work, which is supported by the findings of others (De Haan et 
al., 1998; Fu et al., 1999a; 1999b), there is solid evidence for the role of GPx1 
as a protector against acute oxidative stress.  An additional related finding by 
Fu et al., (2001) is that while GPx1 knockout increases hepatocyte sensitivity 
to the ROS produced by the superoxide generator diquat, it protects against 
peroxynitrite induced apoptosis.  
 
Glutathione Peroxidase 2 
 Gastrointestinal glutathione peroxidase, (GI-GPx or GPx2) is closely 
related to GPx1 in terms of structure and substrate specificity but differs in 
tissue distribution, GPx2 being almost exclusively expressed in the GI tract, 
specifically in the crypts of the intestinal epithelium (Utsunomiya et al., 1991; 
Chu et al., 1993; Esworthy et al., 1997). In addition, the mRNA of GPx2 is 
much more resistant to Se deficiency than that of either GPx1 or GPx3, 
suggesting an important physiological role (Weitzel et al., 1990; Chu et al., 
1997; Wingler et al., 1999; Brigelius-Flohe, 1999). Mice lacking both GPx1 and 
GPx2 (GPx1/2-KO) exhibit severe ileocolitis at a early age whereas mice that 
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have one intact copy of GPx2 have a much lower incidence of inflammatory 
bowel symptoms (Thompson et al., 1998; Esworthy et al., 2001; 2003). 
GPx1/2-KO mice also have microflora-associated cancers in the lower GI tract 
with 25% of mice colonized with Helicobacter species developing ileal and 
colonic tumors (Chu et al., 2004). 
 
Glutathione Peroxidase 3 
Plasma glutathione peroxidase or GPX3 is an extracellular glycosylated 
enzyme (Bjornstedt et al., 1994; Tham et al., 1998) which can reduce 
hydrogen peroxide, lipid hydroperoxides and phospholipid hydroperoxides, 
although with slower catalytic rates than other selenoperoxidases (Esworthy et 
al., 1991; Yamamoto and Takahashi,1993). Since it functions as a tetramer, 
has a similar molecular weight and similar substrate specificty, GPx3 was 
originally considered to be the same as GPx1, but later found to have different 
biochemical characteristics and distinct regulation (Cohen et al., 1985; 
Takahashi and Cohen, 1986; Cohen and Avissar, 1994). The cDNA of GPx3 
contains 5 exons, is approximately 10kb in length  (Yoshimura et al., 1994) 
and has 44% homology with human GPx1 (Yoshimura et al., 1994). It encodes 
226 amino acids with a SeCys at position 73 (Takahashi et al., 1990) has a 
molecular mass of 92kDa (Cohen and Avissar, 1994). GPx3 is primarily 
produced in the kidney and exported as a glycoprotein into plasma (Yoshimura 
et al., 1991). Although it is able to reduce peroxides and phospholipid 
hydroperoxides in vitro (Esworthy et al., 1993), the concentration of plasma 
GSH is believed to be too low for this function (Cohen and Avissar, 1994) and 
therefore it is hypothesized to protect against peroxides in the renal 
extracellular space (Maser et al., 1994), the fluid of lung epithelium and 
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interstitial space (Avissar et al., 1996) and the intestinal intercellular space 
(Tham et al., 1998). 
 
Glutathione Peroxidase 4 
Phospholipid hydroperoxide glutathione peroxidase or GPx4 (EC 
1.11.1.12) was discovered by Ursini et al. (1982) as a selenoprotein in pig liver 
extract with the ability to protect cellular lipids against peroxidation and to 
reduce phosphatidylcholine hydroperoxides. Being distinct from cellular 
glutathione peroxidase-1 (GPx1) (Schukelt et al., 1991), GPx4 is expressed as 
three isoforms with alternate start codons and exons: a 23 kDa form (with a 27 
amino acid mitochondrial targeting sequence that is later cleaved), a 20 kDa 
non-mitochondrial form and a 34 kDa sperm nucleus form (with an alternate 
first exon) (Pushpa-Rekha et al., 1995; Arai et al., 1996). Compared with other 
selenoperoxidases, GPx4 shares approximately 30 to 40 % nucleotide identity 
(Imai and Nakagawa, 2003). The enzyme functions as a monomer rather than 
a tetramer (as in the case of other GPx proteins), and it is the only GPx that is 
able to reduce phospholipid hydroperoxides (Ursini et al., 1985). Nutritionally, 
GPx4 is much more resistant to dietary Se deficiency than the other GPx 
enzymes, particularly GPx1.  When liver GPx1 activity and protein are reduced 
to nearly zero in selenium-depleted rodents (Weitzel et al., 1990; Lei et al., 
1995; Bermano et al., 1996), liver GPx4 activity maintains approximately 20% 
of the selenium adequate levels (Weitzel et al.,1990; Thompson et al., 1998).  
GPx4 was initially suggested as an important antioxidant enzyme (Ursini et 
al., 1985; Wang et al., 2001; Yant et al., 2003; Ran et al., 2003; 2004).  Yant 
et al. (2003) found that GPx4 hemizygous mice were more sensitive to gamma 
irradiation than WT mice, presumably due to induction of free radicals. In 
addition, they found that GPx4 +/- murine embryonic fibroblasts were more 
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sensitive to an assortment of pro-oxidants. However, this function of GPx4 has 
not been tested in vivo. 
Yant et al., (2003) found that a full knockout of gpx4 in mice is lethal at 
embryonic day 7.5 and postulated an essential function of GPx4 in 
development. It is well known that GPx4 protein and activity are very high in 
testes (Weitzel et al., 1990; Roveri et al., 1992). Ursini et al. (1999) reported 
that GPx4 is involved in sperm maturation and serves a structural role in the 
sperm tailpiece in an oxidatively cross-linked state. In addition, Foresta et al. 
(2002) found a causative link between selenium deficiency and male infertility 
and Behne et al. (1996) found that Se deficient rats produce abnormal sperm 
and show decreased fertility. Conrad et al. (2000) made a preliminary report of 
abnormal sperm and focal necrotic lesions in the testes of mice chimeric for a 
full knockout of GPx4. Due to its important functions in sperm maturation and 
high levels in the testes, it has been assumed that the detrimental effects of 
selenium deficiency on male reproductive function are mediated through 
GPx4. However, the relative portion of total tissue Se in the form of GPx4 
protein and the effect of GPx4 expression on the expression of other 
selenoperoxidases are unclear and could not be determined using 
conventional selenium-deficient animal models. 
 
Copper, Zinc and the Superoxide Dismutases 
Copper and zinc serve as components of proteins important for cytosolic 
antioxidant defense. A primary example of this is copper, zinc superoxide 
dismutase (SOD1, EC 1.15.1.1), which catalyzes the dismutation of hydrogen 
peroxide to oxygen and hydrogen peroxide which is then reduced to water by 
the action of the selenoprotein glutathione peroxidases (see Figure 1.1 and 
Figure 1.2) (McCord and Fridovich, 1969; Flohe et al., 1973; Rotruck et al., 
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1973). In addition to its activity in oxidant defense, copper, as a redox active 
metal can also participate in the production of free radicals by interaction with 
thiols (e.g. reduced glutathione) and oxygen. In situations of high intracellular 
hydroperoxide concentrations, copper (and more classically, iron) also has the 
potential to participate in Fenton reactions (Figure 1.3) which produce 
hydroxyl radicals (Oshino et al., 1973). Due to its potentially damaging 
reactivity, there are high levels of copper scavenging proteins in the cell, 
maintaining free copper ion concentrations at near zero (Rae et al., 1999). 
Among these scavenging proteins are the metal binding proteins, the 
metallothioneins, the expression of which can be induced by copper (Murata et 
al., 1999). Copper plays a vital role as a co-factor for a number of 
metalloenzymes including: 
• Cu/Zn superoxide dismutase (antioxidant defense), 
• cytochrome c oxidase (mitochondrial respiration),  
• lysyl oxidase (formation of connective tissue), 
• tyrosinase (melanin synthesis) 
• ceruloplasmin (iron homeostasis) (Pena et al., 1999; Shim and 
Harris, 2003)  
Many of the symptoms associated with copper deficiency are a consequence 
of decreased activity of copper-dependent enzymes (Prohaska, 1991; Milne 
and Nielsen, 1996; Turnlund et al.,1997; Kehoe et al., 2000) although overt 
copper deficiency is rare in humans.  
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Figure 1.1. The established function of Superoxide Dismutases. SOD function 
proceeds by two sequential reactions with superoxide giving an overall 
reaction of (c).   from Liochev et al., (2003) 
 
 
 
 
 
 
 
 
Figure 1.2. The Superoxide Dismutase – Glutathione Peroxidase ROS 
Pathway. Modified from Klotz et al., (2003) 
 
Fe2+ + H2O2 > Fe3+ + OH° + OH
- 
 
Figure1.3. The Fenton reaction. This is the iron-salt-dependent decomposition 
of hydrogen peroxide, generating the highly reactive hydroxyl radical, possibly 
via an oxoiron(IV) intermediate. from: Compendium of Chemical Terminology, 
page 1274  
 
Originally known as erythrocuprein, copper, zinc superoxide dismutase 
(SOD1) (EC 1.15.1.1) was the first SOD identified (McCord and Fridovich, 
1969). Now three distinct superoxide dismutases are known in mammals, with 
their genomic structure, cDNA, and proteins described. Two of these SOD 
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isoforms have copper and zinc in their catalytic center, cytosolic SOD1 and 
extracellular SOD3. SOD1 is a homodimer of about 32kDa (Chang et al., 
1988; Keller et al., 1991; Crapo et al., 1992; Liou et al.,1993). First detected in 
human plasma, lymph, ascites, and cerebrospinal fluids (Marklund et al., 1982, 
1986), SOD3 functions as a homotetramer of 135 kDa (Marklund, 1982). The 
third SOD isoform, MnSOD or SOD2, contains manganese (Mn) as a cofactor 
and has been localized to the mitochondria of aerobic cells (Weisiger and 
Fridovich, 1973). 
The genomic sequence for SOD1 shows striking similarity among 
species being made up of five exons and four introns (Levanon et al.,1985; 
Benedetto et al., 1991; Hsu et al., 1992; Kim et al., 1993)   The promoter 
region of human SOD1 has putative binding sites for the transcription factors 
NF1, Sp1, AP1, AP2, GRE, HSF, and NF-κB (Kim et al., 1994).   A number of 
different mutations in SOD1 have been associated with amyotrophic lateral 
sclerosis (ALS) or Lou Gehrig’s disease (Rosen et al., 1993). However, these 
seem to be “gain of function” mutations, altering SOD1’s substrate affinity, 
decreasing its zinc binding ability or causing increased enzyme aggregation in 
motor neurons (Chou et al., 1996; Wiedau-Pazos et al., 1996; Bruijn et al., 
1998; Estevez et al., 1999). In further support of this, deletion of SOD1 in 
knockout mice does not cause any motor neuron abnormalities (Reaume et 
al., 1996).  
SOD1 catalyzes the reactions depicted in Figure 1.1, producing 
hydrogen peroxide and molecular oxygen from superoxide and protons with 
redox cycling of copper (McCord and Fridovich, 1969; Liochev and Fridovich, 
2003). Hydrogen peroxide can then be detoxified by the glutathione 
peroxidases (See Figure 1.2). However, in the case of an imbalance of 
superoxide production and SOD function, superoxide can accumulate in the 
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cell. Likewise, when hydrogen peroxide production outpaces GPx activity, a 
buildup can occur. When this happens, there is opportunity for these toxic 
metabolites to damage biomolecules. Hydrogen peroxide can undergo the 
Fenton reaction (See Figure 1.3) to produce the very highly reactive hydroxyl 
radical (See Compendium of Chemical Terminology, p.1274). 
Ho et al., (1998) generated mice deficient in SOD1 by gene-targeting 
technology. These mice lacked both SOD1 mRNA expression and SOD1 
enzyme activity in all tissues examined. These SOD1 knockout (SOD1-/-) mice 
developed normally and appeared healthy and even showed no change in 
sensitivity to hyperoxia (Ho et al., 1998). However, the SOD1-/- mice did show 
increased sensitivity to acute paraquat toxicity, myocardial 
ischemia/reperfusion injury, and N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- 
induced dopaminergic neurodegeneration (Ho et al., 1998; Yoshida et al., 
2000; Zhang et al., 2000). Another significant finding by Ho et al., (1998) is 
that SOD1-/- female mice have greatly reduced fertility compared to those with 
one (SOD1+/-) or two (SOD1+/+) functional copies of SOD1 although the 
mechanism for this remains unexplained. 
 
Acetaminophen: inducer of reactive nitrogen species and oxidative 
stress 
 Although it is considered very safe at normal doses, the analgesic and 
antipyretic acetaminophen (AP) can produce a potentially fatal centrilobular 
hepatic necrosis when an overdose is taken (Prescott, 1980). Overdose of AP 
is one of the most common pharmaceutical product poisonings in the United 
States (Litovitz et al., 2002).  Although the precise mechanisms of hepatocyte 
death are not well understood, necrosis, rather than apoptosis is recognized 
as the mode of cell death (Lawson et al.,1999; Gujral et al., 2002). 
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Acetaminophen is metabolically activated by cytochrome P450 by a direct 
two-electron oxidation to form N-acetyl-p-benzoquinoneimine (NAPQI). NAPQI 
is then able to covalently bind to protein (Mitchell et al., 1973; Dahlin et al., 
1984), potentially altering or eliminating function. Several cytochromes, 
primarily P450 2E1, (Patten et al., 1993; Thummel et al., 1993; Chen et al., 
1998) have been reported to be involved in the production of NAPQI. 
Detoxification of NAPQI is thorough conjugation with GSH to form an AP-GSH 
conjugate which can then be eliminated.  However, in the case of a toxic dose, 
total hepatic GSH is depleted and NAPQI binds to thiol groups on proteins 
forming AP-protein adducts (Mitchell et al., 1973). The progression of toxicity 
to produce hepatic cell death following protein adduct formation is poorly 
understood. It is hypothesized that AP adduct formation with important 
proteins can disrupt cellular function, leading to cell death. Primary cellular 
targets may be mitochondrial proteins and proteins involved in cellular ion 
homeostasis (Nelson, 1990). 
Oxidative stress may also contribute to AP toxicity since during formation 
of NAPQI by cytochrome P450, the superoxide anion is formed. Subsequently, 
through SOD activity, hydrogen peroxide is formed (Dai and Cederbaum, 
1995).  In support of this, Nakae et al., (1990) reported that administration of 
encapsulated superoxide dismutase decreased the toxicity of acetaminophen 
in the rat. It is postulated that under conditions of depleted GSH and 
consequent decreased GPx activity, hydrogen peroxide concentrations could 
increase and Fenton-type peroxidation reactions could occur (Nakamura et al., 
1974; James et al., 2003). 
  Nitrotyrosine, an excellent biomarker of peroxynitrite formation (Kaur 
and Halliwell, 1994), has been observed in liver and sinusoidal endothelial 
cells (Hinson et al., 1998; Knight et al., 2001; Knight and Jaeschke, 2004) of 
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AP treated mice. In addition, time course studies indicated that nitrotyrosine 
preceded or developed parallel to cell injury in both hepatocytes and 
endothelial cells (Knight et al., 2001). Peroxynitrite (PN) is formed by a 
reaction between nitric oxide (NO) and superoxide and some researchers 
have found increased NO synthesis during AP toxicity. (Hinson et al., 1998) In 
addition to nitrating tyrosine, PN is a pro-oxidant which can damage 
biomolecules (Pryor and Squadrito,1995). GPx is believed to be a key enzyme 
in detoxifying PN and due to GSH depletion its activity is reduced (Sies et al., 
1997), leading to a decreased ability to deal with oxidative stress. However, 
GPx1 detoxification of PN is still debatable since some research has found 
that hepatocytes from GPx1-/- mice are resisitant to PN induced mortality (Fu 
et al., 2001).  
 Reports regarding whether PN formation is responsible for cellular 
injury are conflicting. Some have found partial protection against AP induced 
liver damage with inducible Nitric Oxide Synthase (iNOS) inhibitors and in 
iNOS knockout mice (Gardner et al., 1998; 2002). Others did not observe 
these protective effects (Michael et al., 2001; Hinson et al., 2002). Knight et 
al., (2001) suggested that PN formation occurred without iNOS induction, 
indicating that NO production by a constitutively expressed NOS produces 
sufficient NO for PN production. 
 GSH is able to detoxify PN in vitro and prevent nitrotyrosine formation 
(Kirsch et al., 2001; Knight et al., 2002). Decreased GSH following AP 
overdose may contribute to both protein nitration and PN toxicity (Knight et al., 
2002). 
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Diquat and Paraquat, Inducers of Reactive Oxygen Species 
Diquat dibromide (DQ; 1,1’-ethhylene-2,2’-dipyridylium dibromide) is an 
herbicide that has been associated with acute liver necrosis. The molecule is 
oxidized to a cation that reacts quickly with oxygen to reform the parent 
compound and a molecule of superoxide. This redox cycling continues as long 
as reducing equivalents are available and is able to produce large amounts of 
superoxide with only a small amount of DQ and unlike many toxicants it is not 
detoxified by alkylation or conjugation. Toxicity is due to oxidative stress 
(Daniel and Gage, 1966; Spalding et al., 1989) causing protein thiol oxidation 
and lipid peroxidation, inducing necrosis in vivo (Smith 1985; 1987a; 1987b). 
The liver is a primary target of these toxic effects (Burk et al., 1995). 
Paraquat (PQ or methyl viologen; 1’-dimethyl-4,4’-bipyridylium dichloride) 
is a compound with biochemical properties similar to those of DQ. It is a widely 
used herbicide that is toxic to both plants and animals (Bus, 1976). At high 
doses most PQ is accumulated in the lung and eliminated by the kidney 
(Smith, 1987c). Due to structural similarities, preferential transport to the lung 
is believed to be via an endogenous polyamine pathway into type I and type II 
alveolar epithelial cells (Gordonsmith et al., 1983). In humans, a non-toxic 
dose is 90% eliminated into urine by the kidney within12 – 24 h (Bismuth et al., 
1987). In the case of a toxic dose, the renal tubule cation transport system 
eliminates PQ (Groves et al., 1995). Similar to DQ, PQ is reduced to a radical 
form by a NADPH dependent pathway. The PQ radical then reacts with 
molecular oxygen to form a PQ cation and superoxide anion. By being 
reduced to a radical again, PQ can repeatedly cycle and produce large 
amounts of superoxide. Cagen and Gibson (1977) showed that Se deficient 
mice were sensitive to PQ toxicity and Cheng et al., (1998) showed in a GPx1 
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knockout mouse model that GPx1 was the mediator of selenium’s protection 
against acute paraquat induced oxidative stress. 
 
Plasma Alanine Aminotransferase and Protein Carbonyl 
 Plasma alanine aminotransferase (ALT) is a frequently used in clinical 
settings to assess liver function. Activity of ALT can increase rapidly in the 
plasma in the presence of xenobiotics that cause liver necrosis (e.g.  AP and 
DQ) (Daniel and Gage, 1966; Prescott, 1980; Flanagan et al., 1995). ALT 
stored in hepatocytes is released when hepatocytes are acutely damaged. 
Increases in plasma concentrations of this enzyme provide important evidence 
of hepatocyte damage (Rosenthal et al., 1997).  
 Protein carbonyl is commonly used as a marker of generalized 
oxidative damage within the cell. Since the addition of carbonyl groups to 
proteins by oxidative modification occurs by many mechanisms, it can provide 
useful information about many oxidative processes. The accumulation of 
oxidized protein is dependent on many factors including: rates of ROS 
formation, antioxidant levels, and the ability to proteolyze and eliminate 
oxidized proteins (For review, see: Stadtman and Levine, 2003). 
 
Unanswered Research Questions 
 Previously, whole animal work on GPx4 was limited to Se deficient 
models which could not specifically address GPx4 without involvement of 
other selenoproteins. Since it is resistant to Se depletion and a full knockout is 
embryonic lethal, this protein apparently has necessary functions. Many 
questions have not been addressed in whole animal models due to the 
limitations of older models. Since this half-knockout model provides the first 
opportunity to independently test effects of reduced GPx4, we have used 
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these mice to address the following questions in Experiment 1: Are there 
changes in the expression of GPx4 in various tissues of haploid insufficient 
mice? Does altered GPx4 expression have an effect on tissue selenium 
concentration or the expression of other selenoperoxidases? Does GPx4 have 
an antioxidant function that is compromised by deletion of one gpx4 gene? 
Given the important functions for reproduction and high expression of GPx4 in 
the testis, are there any apparent changes in the fertility of male mice? 
 Oxidative (involving ROS) and nitrosative (involving RNS) processes 
are involved in many processes in the cell, some physiologically normal and 
others which can disrupt normal cell function. Reactive oxygen species are a 
by-product of aerobic metabolism which can cause cellular damage. It has 
been assumed that loss of function of antioxidant enzymes (e.g. GPx1 or 
SOD1) is detrimental under nearly all conditions. However, previous work in 
our lab has shown that this is not always the case since GPx1 knockout 
decreased hepatocyte sensitivity to peroxynitrite (Fu et al., 2001) and 
increased hepatocyte and whole animal ROS sensitivity. In Experiment 2 we 
address the following questions: Does this opposite relationship of ROS/RNS 
sensitivity also hold true in the whole animal? Does knockout of a different 
antioxidant enzyme (SOD1) have a similar effect?  How does partial or 
complete loss of SOD1 and GPx1 genes in combination affect these 
responses? How does partial or complete loss of SOD1 and GPx1 genes in 
combination affect enzyme activities? 
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Objectives: 
Experiment 1 
To examine the effect of deletion of a single copy of gpx4 on: 
1. The activities of three selenoperoxidases (GPx1, GPx3, and GPx4) in 
lung, liver, kidney and testis 
2. Selenium concentrations in lung, liver, kidney and testis 
3. Susceptibility to pro-oxidant-induced protein oxidation in lung, liver, 
kidney and testis 
4. Fertility in male mice 
 
 
Experiment 2 
To use mouse models carrying mixed SOD1 and GPx1 knockouts (possessing 
0, 1 or 2 functional copies of each gene in various combinations) to:  
1. Determine effect of various combinations of GPx1 and SOD1 gene 
dosage on GPx1 and SOD activity 
2. Determine effect of GPx1 and SOD1 gene dosage separately and in 
combination on mouse susceptibility to diquat and acetaminophen 
toxicity and lethality 
3. Examine effect of diquat and acetaminophen toxicity on ALT, GPx1 and 
SOD enzyme activity 
 
 
CHAPTER 2: 
MATERIALS AND METHODS 
 
  All chemicals and materials were purchased from Sigma Chemical (St. 
Louis, MO) unless otherwise indicated. 
 
Mice 
Animal care 
 Mice were bred and housed in the facilities of the Department of 
Animal Science at Cornell University. All mice were housed in standard 
“shoebox” style cages (n=1-4 per cage) on stainless steel racks at 70-72°F 
and 35-55% humidity with12 h light/12 h dark cycle.  All mice were given 
distilled water ad libitum. Mice from Experiment 1 were fed a vitamin E and 
selenium adequate diet (90.18 IU/kg and 0.33 mg/kg, respectively) (rodent diet 
#8604, Harlan-Teklad Madison, WI) ad libitum. In Experiment 2, mice were fed 
5 g/d of a torula yeast based Se adequate diet previously described by Cheng 
et al., (1997). All studies were approved by the Institutional Animal Care and 
Use Committee at Cornell University and conducted in accordance with NIH 
guidelines for animal care.  
 
Experiment 1. GPx4 Knockout Mice 
 GPx4+/- mice (generation described by Yant et al., 2003) were 
provided by Dr. Tomas Prolla of the University of Wisconsin at Madison. As 
GPx4 nullizygous is embryonic lethal, all mice born were either GPx4+/- or 
WT, providing an internal control. Mice were genotyped by a PCR method. 
Primers for detection of GPx4 wild-type and knockout alleles are:  
22 
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Forward primer: 5’-GGCCTGGTTTCTATGTA-3’    
Wild-type reverse primer: 5’-CCCCTGCCCTTCTGGACTATTGG-3’  
Knockout reverse primer: 5’-GCACACTGGCAAAACAATGC-3’ . 
 
Experiment 2. GPx1 and SOD1 Knockout Mice 
Generation and characterization of GPx1 and SOD1 knockout mice was 
previously described by Ho et al., (1997, 1998). Both strains of mice were 
interbred and produced offspring carrying 0, 1 or 2 functional copies of each 
gene. Mice were genotyped by PCR. Primers for detection of GPx1 wild-type 
and knockout alleles are:  
Forward primer: 5'-GTTTCCCGTGCAATCAGTTCG-3'  
Wild type reverse primer: 5'-TCGGACGTACCCTTGAGGGAAT-3'  
Knockout reverse primer: 5'-CATTTGTCACGTCCTGCAC-3'  
Primers for detection of SOD1 wild-type and knockout alleles are:  
Forward primer:  5’-GGACATCGTGTGATCTCACTCTCAGGAGAG-3’ 
Wild type reverse primer: 5’-CAAGCGGCTCCCAGCATTTCCAGTCTTTGT-3’ 
Knockout reverse primer:     5’-
AAAAGCGCCTCCCCTACCCGGTAGAATTGA-3’ 
 
Treatments 
  Experiment 1. Paraquat: Mice were given IP injections with 24 mg/kg 
body weight paraquat (methyl viologen, PQ) as 2.4 mg PQ/ml in phosphate 
buffered saline, 0.2 micron sterile filtered or an equivalent volume of sterile 
filtered phosphate-buffered saline (PBS). Mice were euthanized 4 h post-
injection by carbon dioxide asphyxiation followed by exsanguination with a 
heparinized syringe. 
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Experiment 2. Diquat and Acetaminophen: Mice were given 
intraperitoneal (IP) injections with 24mg/kg body weight diquat (diquat 
dibromide, DQ) as 2.4 mg DQ/ml in phosphate bufered saline (PBS) or 600 
mg/kg body weight acetaminophen (paracetamol, AP)  as 60 mg AP/ml in PBS 
or an equivalent volume of PBS. All solutions were 0.2 micron sterile filtered 
prior to injection. Mice were monitored until death, for up to 72 hours. Tissue 
and plasma samples from mice that died were collected immediately after 
death, mice which survived to 72 hours were euthanized by carbon dioxide 
asphyxiation followed by exsanguination with a heparinized syringe. 
 
Sample Collection and Preparation 
Experiment 1. Two plasma samples were taken from the blood post-
exsanguination. One was used fresh for plasma alanine aminotransferase 
activity assay and one was snap frozen in liquid nitrogen for later GPx3 
analysis. Lung, liver, kidney and testes were collected, rinsed in 0.9% saline 
and snap frozen in liquid nitrogen. All frozen samples were stored at -80°C. 
Experiment 2. A fresh plasma sample was used for plasma alanine 
aminotransferase activity (ALT) assay. Liver was collected, rinsed in 0.9% 
saline, snap frozen in liquid nitrogen and stored at -80° C. 
 
Enzyme assays 
 Plasma alanine aminotransferase activity (plasma ALT) was assayed 
using the Infinity ALT reagent (Thermo Electron Corp. Waltham, MA) at 30°C, 
according to manufacturer’s instructions. Tissue homogenates were prepared 
as described in Cheng et al., (1997). In brief: 1:20 dilutions (w/v) of tissue in 
homogenization buffer (0.25 mol/L sucrose containing 20 mmol/L Tris-HCl, pH 
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7.4 for GPx1 and GPx3, 0.25 mol/L sucrose containing 20 mmol/L Tris-HCl, 
pH 7.4, 0.1% triton, for GPx4) were homogenized on ice and centrifuged at 
105,000g for 1 hour. Supernatants were collected and frozen at –80°C. 
Activities of GPX1 and GPX4 in tissue homogenates and plasma were 
measured by the NADPH coupled assay, using hydrogen peroxide and 
phosphatidylcholine hydroperoxide as substrate, respectively (Cheng et al., 
1997). Protein was measured by the Lowry method (Lowry et al., 1951) and 
enzyme activity expressed as Units/mg protein. Superoxide Dismutase activity 
was measured in GPx1/SOD1 liver using the SOD Assay Kit - WST from 
Dojindo (Gaithersburg, MD) according to manufacturer’s instructions.  
 
Tissue Selenium Concentration 
Tissue selenium concentration was determined on whole tissue 
samples using the improved fluorometric method of Olson et al., (1975) and 
expressed as μg/g wet tissue weight. 
 
Protein Carbonyl 
As a hallmark of protein oxidation, total protein carbonyl was 
determined by a spectrophotometric method based on Levine et al., (1994) 
and Reznick and Packer (1994) and expressed as nmol/mg protein.  
 
Statistics 
Data were analyzed using SAS (release 9.1, SAS Institute, Cary, NC). 
Significance was defined as P < 0.05 and results are expressed as mean ± 
SEM. 
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Experiment 1. Data were analyzed using the GLM procedure in SAS as 
a 2 x 2 factorial ANOVA. Tukey’s test was used for mean comparisons.  
 
Experiment 2. Treatment survival was modeled in two ways using SAS. 
Both a general linear model (GLM procedure) and survival analysis model 
(TPHREG procedure) were used to compare the effects of genotype and 
treatment. For the general linear model, the outcome measure survival time 
was assigned four classes (1 = <20 h, 2 = >20 - 40 h, 3=>40 h - <72 h, 
4=survived experiment, 72+ h) and was used with genotype and treatment as 
predictors in a multi-factorial ANOVA to determine main effects. Scheffe’s test 
was used for mean comparisons. The TPHREG procedure is based on the 
Cox proportional hazards regression and produces a description of a time 
dependent survival curve. Genotypes were classified according to copy 
number of either WT or KO genes [e.g. -/+ = 1(-) or 1(+) and -/- = 2(-) or 0(+)]. 
To separate effects of each gene (GPx1 or SOD1), analyses were stratified for 
the copy number of the other gene (SOD1 or GPx1). Models using all factors 
were also employed to determine effects in each experimental group. Hours of 
survival was used as the outcome measure (Allison, 1995; Hosmer and 
Lemeshow, 1999). 
Enzyme values were also analyzed by the GLM procedure, using the 
same survival time classification described above. Enzyme values were then 
grouped by and analyzed as a multi-factorial ANOVA with survival class, GPx1 
genotype, SOD1 genotype and treatment as predictors with Tukey’s test for 
mean comparisons. For all statistical analyses, significance was defined as 
P<0.05. 
  
CHAPTER 3: 
EFFECTS OF GPX4 HAPLOID INSUFFICIENCY ON GPX4 ACTIVITY, 
SELENIUM CONCENTRATION, AND PARAQUAT-INDUCED PROTEIN 
OXIDATION IN VARIOUS TISSUES OF MICE 
 
Abstract 
  Selenium-dependent glutathione peroxidase-4 (GPx4) catalyzes the 
reduction of phospholipid hydroperoxides. Since a full gpx4 knockout is 
embryonic lethal, we examined the effect of deletion of one copy of gpx4 on 
the activities of three selenoperoxidases (GPx1, GPx3, and GPx4), selenium 
concentrations, and pro-oxidant-induced protein oxidation in various tissues of 
mice.  A total of 32 GPx4 hemizygous (GPx4+/-) and wild-type (WT) mice (8-
10 weeks old, 16 males and 16 females) were fed a selenium-adequate diet 
and given an intraperitoneal injection of paraquat (PQ, 24 mg/kg of body 
weight) or phosphate buffered saline (PBS). All mice were euthanized 4 h after 
injection to collect tissues for analyses. In PBS-treated mice, GPx4 activities in 
lung, liver, kidney, and testes of GPx4+/- mice were 24-39% lower (P < 0.05) 
than in WT. Among PQ-treated mice, only testes GPx4 activity in GPx4+/- 
mice was significantly lower (54%, P < 0.05) than WT. Selenium concentration 
in testes, but not in other tissues, was reduced (34%, P < 0.05) in GPx4+/- 
mice compared with WT, irrespective of treatment. Tissue GPx1 activities and 
plasma GPx3 and alanine aminotransferase activities were unaffected by PQ 
treatment or gpx4 hemizygosity. Total protein carbonyl was elevated (73%, P 
< 0.05) by PQ only in lung, and this effect of PQ was independent of 
genotypes.  In conclusion, gpx4 haploid insufficiency reduced GPx4 activities 
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and(or) selenium concentrations, but had no effect on pro-oxidant-induced 
protein oxidation in various tissues of mice.  
 
Introduction 
 Phospholipid hydroperoxide glutathione peroxidase or GPx4 was 
discovered by Ursini et al., (1982) as a new selenoprotein from pig liver extract 
with the ability to protect cellular lipids against peroxidation and to reduce 
phosphatidylcholine hydroperoxides. Being distinct from cellular glutathione 
peroxidase-1 (GPx1) (Schuckelt et al.; 1992), GPx4 is expressed as three 
isoforms with alternate start codons and exons: a 23 kDa form (with a 27 
amino acid mitochondrial targeting sequence that is later cleaved), a 20 kDa 
non-mitochondrial form and a 34 kDa sperm nucleus form (with an alternate 
first exon) (Pushpa-Rekha et al., 1995; Arai et al., 1996). Compared with other 
seleno-GPx proteins, GPx4 shares approximately 30 to 40 % nucleotide 
identity (Imai and Nakagawa, 2003). The enzyme functions as a monomer 
rather than a tetramer (as in the case of other GPx proteins), and it is the only 
GPx that is able to reduce phospholipid hydroperoxides (Ursini et al,. 1985). 
Nutritionally, GPx4 is much more resistant to dietary Se deficiency than the 
other GPx enzymes, particularly GPx1.  When liver GPx1 activity and protein 
are reduced to nearly zero in selenium-depleted rodents (Weitzel et al., 1990; 
Lei et al., 1995; Bermano et al., 1996), liver GPx4 activity maintains 
approximately 20% of the selenium adequate levels (Weitzel et al., 1990; 
Thompson et al., 1998). However, the relative portion of total tissue Se in the 
form of GPx4 protein and the effect of GPx4 expression on the expression of 
other selenoperoxidases in various tissues are unclear, and could not be 
determined using conventional selenium-deficient animal models.  
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Yant et al., (2003) found that a full knockout of gpx4 in mice is lethal at 
embryonic day 7.5 and postulated an essential function of GPx4 in 
development. It is well known that GPx4 protein and activity are very high in 
testes (Weitzel et al., 1990; Roveri et al., 1992). Ursini et al., (1999) reported 
that GPx4 is involved in sperm maturation and serves a structural role in the 
sperm tailpiece in an oxidatively cross-linked state, offering an explanation for 
the detrimental effects of Se deficiency on male reproductive function (Foresta 
et al., 2002). In addition, GPx4 has been proposed as a modulator of 
inflammatory lipid signaling molecules of various eicosanoids (Haurand and 
Flohe, 1988; Weitzel and Wendel, 1993; Schnurr et al., 1996; Imai et al., 1998; 
Huang et al.. 1999). However, GPx4 was initially suggested as an important 
antioxidant enzyme (Ursini et al., 1985). Although GPx4 haploid insufficiency 
was shown to render murine embryonic fibroblasts susceptible to pro-oxidant-
induced oxidative stress (Yant et al., 2003; Ran et al., 2003) such in vivo 
impacts of GPx4 have not been well studied.  
 Since homozygous GPx4 knockout is lethal (Yant et al., 2003), we used 
the newly developed GPx4 hemizygous (GPX4+/-) mice (Yant et al., 2003) in 
the present study to examine the effect of deletion of a single copy of gpx4 on 
the activities of three selenoperoxidases (GPx1, GPx3, and GPx4), selenium 
concentrations, and susceptibilities to pro-oxidant-induced protein oxidation in 
various tissues. Paraquat (methyl viologen, PQ) was chosen as the inducer of 
acute oxidative stress. This pro-oxidant compound primarily targets lung, a site 
of relatively high GPx4 activity (Weitzel et al., 1990; Bus et al., 1974; Smith, 
1987). Since it is believed that PQ promotes the formation of superoxide 
radicals causing oxidative damage to important biomolecules, we chose 
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protein carbonyl formation as an indicator of protein oxidation (Levine et al., 
1994).  
 
Materials and Methods: 
Mice.  The generation of GPx4+/- mice was previously described (Yant et al., 
2003). All mice were bred and housed in the mouse facility at Cornell 
University and were given free access to a selenium adequate (0.33 mg 
Se/kg) rodent diet (#8604, Harlan-Teklad Madison, WI) and distilled water. 
Genotypes of mice were verified by a PCR method modified from the one 
previously described (Yant et al., 2003), using a different reverse knockout 
primer located within the hprt cassette: 5’-gcacactggcaaaacaatgc-3’. Our study 
was approved by the Institutional Animal Care and Use Committee at Cornell 
University and conducted in accordance with NIH guides for animal care.  
 
Experimental Procedure. A total of 32 GPx4+/- and WT mice (half male, half 
female, 8-10 weeks old) were assigned to treatments with PQ or phosphate-
buffered saline (PBS) in a 2 x 2 factorial design (n = 6 to 10 per genotype by 
treatment). Mice were given an ip injection of 24 mg of PQ/kg of body weight 
(PQ was dissolved in PBS at 2.4 mg PQ/mL and passed through a 0.2 micron 
sterile filter) or an equivalent volume of sterile filtered PBS. All mice were 
euthanized at 4 h after injection by carbon dioxide asphyxiation followed by 
exsanguination with a heparinized syringe. The PQ dose and treatment 
interval were chosen based on responses of mice with the same genetic 
background to various doses of pro-oxidants and different lengths of exposure 
time (Cheng et al., 1998; 1999; 2003).  
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Two plasma samples were prepared from the blood: one was used fresh for 
plasma alanine aminotransferase activity assay and the other was snap frozen 
in liquid nitrogen for later GPx3 activity analysis. Lung, liver, kidney and testes 
were collected, rinsed in 0.9% saline and snap frozen in liquid nitrogen. All 
snap frozen samples were stored at -80°C before analysis. 
 
Biochemical Analyses. All chemicals and materials were purchased from 
Sigma Chemical (St. Louis, MO) unless otherwise indicated. Plasma alanine 
aminotransferase (ALT) activity was assayed using the Infinity ALT reagent 
(Thermo Electron Corp. Waltham, MA) at 30°C, according to manufacturer’s 
instructions. Tissue homogenates were prepared as previously described 
(Cheng et al., 1997). Activities of GPx1 and GPx4 in tissue homogenates were 
measured by the NADPH coupled assay, using hydrogen peroxide and 
phosphatidylcholine hydroperoxide as the substrate, respectively (Cheng et 
al., 1997). GPx3 was measured in plasma using the same assay as GPx1. 
Protein was measured by the Lowry method (28). Tissue selenium 
concentration was determined using the improved fluorometric method of 
Olson et al., (1975) and expressed as g/g wet tissue weight. As a hallmark of 
protein oxidation, total protein carbonyl was determined by a 
spectrophotometric method based on Levine et al., (1994) and Reznick and 
Packer (1994) and expressed as nmol protein carbonyl/mg protein.  
 
Statistics. Data were analyzed using the GLM procedure in SAS (release 9.1, 
SAS Institute, Cary, NC) as a 2 x 2 factorial ANOVA for main effects. Tukey’s 
test was used for mean comparisons. Significance was defined as P < 0.05. 
Results are expressed as mean ± SEM. 
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Results 
 All animals survived the PQ injection and were apparently healthy 
throughout the 4 h treatment. Upon euthanasia, no gross abnormalities of 
internal organs were observed. 
Tissue GPx4 and GPx1 Activities. Testes GPx4 activity was 36% (P < 0.05) 
and 54% (P < 0.01) lower in the PBS and PQ-treated GPx4+/- mice than that 
of the WT mice, respectively (Figure 3.1).  Paraquat treatment enhanced  
testes GPx4 activity in the WT mice (P < 0.05), but not in the GPx4+/- mice. 
Liver, lung, and kidney GPx4 activities in the PBS-treated GPx4+/- mice were 
24, 27 and 39 % lower (P < 0.05) than the PBS-treated WT mice, respectively. 
The PQ treatment did not cause significant difference in GPx4 activities 
between the two genotypes in these three tissues. There was no PQ or 
genotype effect on GPx1 activities in any of these tissues (Table 3.1). 
Plasma ALT and GPx3 Activities. The PQ injection caused no changes in 
plasma ALT or GPx3 activities in either genotype (Table 3.1). There were no 
genotype differences in plasma ALT or GPx3 activities within either treatment.  
Tissue Selenium Concentrations. Testes selenium concentration in the 
GPx4+/- mice was 34% lower (P < 0.01) than in WT mice regardless of the 
treatment (Figure 3.2). There was no treatment or genotype effect on selenium 
concentrations of other tissues (Table 3.1). 
Protein Carbonyl Concentrations. Total protein carbonyl in lung of the PQ-
treated mice was 73% higher (P < 0.05) than in the PBS-treated mice, 
irrespective of genotypes (Figure 3.3).  No significant effects of genotype or 
treatment were shown on total protein carbonyl in liver, kidney or testes. 
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Figure 3.1. Effect of GPx4 Knockout and Paraquat Treatment on GPx4 
Activity. PBS treated GPx4+/-  mice showed 22%, 27%, 39% and 36% lower 
activity in the lung, liver, kidney and testes than WT, respectively (P < 
0.05).Values are means ± SEM (n = 3 for testes, n = 6 for other tissues). 
Values with different letters are significantly different at P < 0.05.  
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Table 3.1. Effect of GPx4 hemizygosity and paraquat treatment on GPx1, 
GPx3 and ALT activity and tissue selenium concentrations 
   
No significant changes by genotype or treatment were found in lung, liver, 
kidney and testes GPx1 and plasma GPx3 activity, Plasma ALT activity and 
tissue selenium concentration of lung, liver and kidney. Values are means ± 
SEM, n = 6 for lung liver kidney and plasma, n = 3 for testes. 
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Figure 3.2. Effect of GPx4 Knockout and Paraquat Treatment on Testes 
Selenium Concentration. GPx4+/- testes exhibited a 31 – 37% lower selenium 
concentration than WT (P < 0.05). Values are means ± SEM (n = 3). Values 
with different letters are significantly different at P < 0.05. 
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Figure 3.3. Effect of GPx4 Knockout and Paraquat Treatment on Total Tissue 
Protein Carbonyl. Overall, PQ treated mice had a 73% higher carbonyl 
concentration in the lung than PBS treated control (P < 0.05). Values are 
means ± SEM (n = 3 for testes, n = 6 - 10 for other tissues).Values with 
different letters are significantly different at P < 0.05. 
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Discussion 
 Our results provide us with three major novel findings. First of all, 
deletion of one copy of GPx4 resulted in a 24 to 39% baseline reduction in 
GPx4 activities in liver, lung, kidney, and testes, compared with the WT mice. 
Although Yant et al., (2003) and Ran et al., (2003; 2004) determined GPx4 
mRNA and protein changes in various tissues and cells of GPx4+/- and GPx4 
overexpressing mice, respectively, our study represents the first evidence for 
the effect of GPx4 haploid insufficiency on its enzymatic activity in vivo. Since 
changes in GPx4 mRNA or protein do not necessarily predict the actual 
activity of GPx4, it is necessary to know GPx4 activities in different tissues of 
GPx4+/- mice if the model is to be used for metabolic functional studies. For 
example, Yant et al., (2003) found an approximate 50% reduction in GPx4 
mRNA and protein in the liver of GPx4+/- mice. However, we have found only 
a 24% reduction in GPx4 activity. Similarly, Yant et al., (2003) showed the 
lowest percentage reduction of GPx4 mRNA and protein in testes of GPx4+/- 
mice, whereas we have demonstrated that the GPx4 allelic deletion produced 
the highest percentage change in overall GPx4 activity (average 40% 
decrease in PBS and PQ treated groups) in the testes. Overall, the deletion of 
one allele of gpx4 did not lead to 50% activity reduction in any tissue, contrary 
to some other cases of gene knockout (Huang et al., 1996; Kline et al., 2002; 
McIlvain et al., 2003). Thus, GPx4 activity or expression of the remaining allele 
of gpx4 might be up-regulated somewhat in these tissues to compensate for 
the deletion. 
 Our second interesting finding that GPx4 haploid insufficiency resulted 
in the reduction of selenium concentration in testes, but not in other tissues.  
This implies that a relatively small amount of tissue selenium was associated 
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with the reduction of GPx4 activities in lung, liver and kidneys. In contrast, 
selenium concentration in testes of GPx4+/- was reduced in proportion to the 
activity reduction. Overall, the PBS and PQ-treated animals had an average of 
40% reduction in GPx4 activity and a 34% reduction of testes selenium 
concentration. Accordingly, full expression of GPx4 should account for 85% of 
total selenium in testes. Since the PQ-associated GPx4 increase in activity in 
the testes of WT mice did not alter selenium concentration, post-translational 
regulation of the enzyme might be responsible for these changes under the 
present experimental conditions. A similar GPx4 response to oxidative stress 
has been reported in rat polymorphonuclear neutrophils in which GPx4 activity 
was up-regulated in response to increased oxidative stress during an 
inflammatory challenge (Hattori et al., 2005). Apparently, these up-regulations 
of GPx4 activity by pro-oxidant challenge depend on both genotype and tissue 
or cell type (Hattori et al., 2005). Since tissue GPx1 activities and plasma 
GPx3 activity were unaffected by GPx4+/-, the expression of these two 
selenoperoxidases is independent of that of GPx4. Our data extend a similar 
observation by Ran et al., (2003) in embryonic fibroblasts of GPx4+/- and are 
consistent with the impact of GPx4 overexpression on tissue GPX1 activity in 
mice (Ran et al., 2004). Conversely, Cheng and colleagues showed 
unchanged GPx3 and GPX4 activities in GPx1-/- mice (Cheng et al., 1998a). 
 Our third interesting finding is that reduction of GPx4 activities in liver, 
lung, kidney, and testes of GPx4+/- mice did not sensitize these tissues to the 
PQ-mediated protein-oxidation. This is contrary to the greater susceptibility of 
embryonic fibroblasts derived from GPx4+/- mice than those from wild-type 
mice to oxidative stress inducers of λ-irradiation, PQ, t-butyl hydroperoxide, 
hydrogen peroxide, and normoxic versus hypoxic conditions (Yant et al., 2003; 
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Ran et al., 2003). Obviously, results from cultured cells do not necessarily 
reflect the metabolic role of GPx4 under physiological conditions, and the level 
of oxidative stress employed in these cell studies may be higher than in the 
present study. Although the dose of PQ used in the present study did not 
affect survival or cause changes in plasma ALT activity and gross pathology, it 
did cause a significant increase in protein carbonyl formation in the target 
tissue of lung in both WT and GPx4+/- mice. This induction of protein oxidation 
in lung was comparable to that by other doses of PQ in liver of selenium-
deficient mice in our previous studies (Cheng et al., 1998b; 1999) and in the 
lung of rat in studies by Winter et al., (1991). Thus, the 24 to 39% reduction in 
GPx4 activity in different tissues of GPx4+/- mice was not sufficient to 
compromise defense against pro-oxidant induced protein oxidation.  As 
measurements were made at only one time point following only one level of 
PQ dosage in the present study, future research with various doses of PQ or 
other pro-oxidants targeting different tissues should be tested to further assess 
the role of GPx4 in in vivo anti-oxidation. Paraquat doses > 50 mg/kg body 
weight may produce sufficient oxidative stress to detect differences between 
WT and GPx4+/- mice (Levine et al., 1994). Diquat is structurally and 
functionally similar to paraquat and targets the liver rather than the lung. We 
have found doses of diquat in the range of 24 – 48 mg/kg to be useful for 
detecting changes in anti-oxidation (Fu et al., 1999b). Cadmium is believed to 
damage the testes by oxidative stress (Shen et al., 1995; Liu et al., 2001) 
therefore this heavy metal presents an opportunity to target an important site 
of GPx4 function with oxidative stress in vivo. 
 
 
CHAPTER 4: 
EFFECT OF GPX1 AND SOD1 GENE DOSAGE ON GPX1 AND SOD 
ACTIVITY AND SUSCEPTIBILITY TO ACETAMINOPHEN AND DIQUAT 
TOXICITY AND LETHALITY 
 
Abstract 
 The objective of this study was to investigate the role of gene dosage of 
both GPx1 and SOD1 on acetaminophen (AP) and diquat (DQ) toxicity and the 
effect of these four factors on plasma ALT activity, liver GPx1 activity and liver 
SOD activity. Seventy-one adult mice were distributed to genotype and 
treatment groups, given intraperitoneal injections of 600 mg/kg body weight 
AP, 25 mg/kg body weight DQ or phosphate buffered saline (PBS) control and 
observed for 72 h. Plasma and liver samples were collected at time of death 
for enzyme assays.  Overall, 26.7% of mice (n = 19) died during the 72 h 
experiment. DQ-treated SOD1-/- mice died at <20 h but survived the entire 72 
h experiment with AP treatment. AP-treated SOD1+/+ mice showed a trend 
toward decreased survival but had full survival with DQ treatment. Similar 
general trends were found in both experimental and Cox Proportional Hazard 
(CPH) survival curves: SOD1-/- mice died rapidly from DQ but survived AP; 
SOD1+/+ mice survived DQ but died rapidly from AP; both AP or DQ 
treatment decreased survival of GPx1-/- mice but not GPx1+/+ mice; SOD1+/- 
and GPx1+/- mice had treatment responses intermediate between their 
respective +/+ and -/- genotypes. The effects of both genes were also 
considered: DQ-treated mice with a total of one functional GPx1 or SOD1 
gene copy had significantly shorter survival than control (0-20 h versus >72 h, 
P < 0.05) but had no significant difference in survival when treated with AP. 
40 
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AP-treated GPx1+/-|SOD1+/+ mice had significantly shorter survival time than 
control (20-40 h versus >40 h P < 0.05) and survived DQ treatment.  
Plasma ALT activity response depended on survival time and treatment 
rather than directly on genotype. AP-treated mice which died in <20 h, at 20-
40 h or 40 - <72 h showed significant ALT increases compared to PBS control, 
peaking at 20-40 h survival (3145 ± 877; 11740 ± 1074 and 6297 ± 1074 
versus 152 ± 368 U/litre P < 0.05). DQ-treated mice who died in <20 h also 
had significantly increased ALT activity compared with control (2129 ± 537 
versus 152 ± 368 U/litre P < 0.05). All surviving mice showed no significant 
increases in plasma ALT.  
GPx1 genotype and SOD1 genotype had significant effects on liver 
GPx1 activity. All GPx1-/- and GPx1+/- mice showed significantly lower liver 
GPx1 activity than GPx1+/+ mice (1 ± 32 and 553 ± 30 versus 1014 ± 36 U/mg 
protein, P < 0.05). Among GPx1+/- mice, SOD1-/- had 34% lower liver GPx1 
activity than SOD1+/- (364 ± 40 versus 553±30 U/mg protein, P < 0.05) and 
28% lower activity than SOD1+/+ (364±40 versus 504±36 U/mg protein, P = 
0.0778).  
SOD1 genotype and survival time had significant effects on liver SOD 
activity. PBS treated SOD1-/- and SOD1+/- mice had significantly lower 
activity than SOD1+/+ mice (P < 0.05).  
Although conclusions drawn from this study must be limited due to the 
sample size and low death rates in some groups, certain trends are seen. To 
summarize, the SOD1 knockout allele [SOD1(-)] is associated with decreased 
sensitivity to AP toxicity, increased sensitivity to DQ toxicity and decreased 
liver GPx1 activity and   the GPx1 knockout allele [GPx1(-)] is associated with 
increased sensitivity to both AP and DQ toxicity. 
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Introduction 
 As the first identified mammalian selenoprotein, glutathione peroxidase 
1 (EC: 1.11.1.9, GPx1) is a well characterized antioxidant protein (Flohe et al., 
1972, Cheng et al., 1998b).  GPx1 functions as a homotetramer of 88 kDa and 
each 23 kDa monomer contains one selenocysteine residue.  
 Although evidence in cell culture studies supported the role of GPx1 as 
an antioxidant enzyme (Mirault et al., 1991; Geiger et al., 1993), this function 
was first demonstrated in animals when Cheng et al., (1998b) used GPx1 
knockout mice to show that GPx1 is the mediator of selenium’s protection 
against acute oxidative stress. These findings were supported by the studies 
of others (De Haan et al., 1998) therefore there is now solid evidence for the 
role of GPx1 as a protector against acute oxidative stress.  Interestingly, cell 
culture studies have shown that while GPx1 (Fu et al., 2001) protects against 
ROS produced by the superoxide generator diquat, it sensitizes hepatocytes 
to peroxynitrite induced apoptosis. The mechanism of the inverse relationship 
between sensitization to reactive oxygen species and reactive nitrogen 
species remains unexplained in cells and untested in animals. 
 Along with selenium, copper and zinc serve as cofactors in cytosolic 
antioxidant proteins. Copper, zinc superoxide dismutase (SOD1, EC 1.15.1.1), 
catalyzes the dismutation of superoxide to hydrogen peroxide and oxygen 
which can then reduced to water by the action of GPx1 (see Figure 1.1 and 
Figure 1.2) (McCord and Fridovich, 1969; Flohe et al., 1973; Rotruck et al., 
1973). When superoxide production outpaces its elimination by SOD, 
superoxide can accumulate in the cell. Similarly, when hydrogen peroxide 
production outpaces GPx activity, hydrogen peroxide can accumulate. Under 
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these conditions, there is opportunity for these toxic metabolites to damage 
biomolecules.  
To study the antioxidant role of SOD1, mice deficient in SOD1 (SOD1-/-) 
were generated and characterized (Ho et al., 1998). SOD1-/- mice were 
phenotypically normal and showed no change in sensitivity to hyperoxia (Ho et 
al., 1998). However, SOD1-/- mice did show increased sensitivity to acute 
paraquat (a ROS generator) toxicity and female mice demonstrated greatly 
reduced fertility compared to mice with one (SOD1 +/-) or two (SOD1+/+) 
functional copies of SOD1 (Ho et al., 1998). The mechanism for reduced 
female fertility remains unexplained. 
The analgesic and antipyretic acetaminophen (AP) is considered very safe 
at normal doses but an overdose can produce a potentially fatal centrilobular 
hepatic necrosis (Prescott, 1980). When AP is metabolized, the cytochrome 
P450 system produces multiple metabolites, including N-acetyl-p-
benzoquinoneimine (NAPQI). Normal detoxification of NAPQI is through 
conjugation with GSH to form an AP-GSH conjugate which is then eliminated 
(Mitchell et al., 1973). However, in the case of a toxic dose, total hepatic GSH 
is depleted and NAPQI can form AP-protein adducts (Mitchell et al., 1973).  In 
addition to NAPQI, the superoxide anion is also formed and it is believed that 
ROS contributes to AP toxicity. In support of this, Nakae et al., (1990) reported 
that administration of encapsulated superoxide dismutase decreased the 
toxicity of acetaminophen in the rat. 
  Reactive nitrogen species (RNS) may also play a role in AP toxicity. 
Nitrotyrosine, an excellent biomarker of peroxynitrite formation (Kaur and 
Halliwell, 1994), has been observed in AP treated mice (Hinson et al., 1998; 
Knight et al., 2001; Knight and Jaeschke, 2004). In addition, timecourse 
studies indicated that nitrotyrosine preceded or developed parallel to cellular 
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injury (Knight et al., 2001). Peroxynitrite (PN) is formed by a reaction between 
nitric oxide (NO) and superoxide. In addition to superoxide production some 
researchers have found increased NO synthesis during AP toxicity (Hinson et 
al., 1998), providing both components of PN formation. In addition to nitration 
of tyrosine residues, PN is a pro-oxidant which can damage biomolecules 
(Pryor and Squadrito,1995). GPx is believed to be a key enzyme in detoxifying 
PN and due to the GSH depletion during of AP toxicity, its activity is reduced 
(Pryor and Squadrito,1995) leading to a decreased resistance to oxidative 
stress. The role of RNS in AP toxicity is still debatable. While some have 
reported partial protection against AP induced liver damage with inducible 
Nitric Oxide Synthase (iNOS) inhibitors and in iNOS knockout mice (Gardner 
et al., 1998; 2002), others did not observe these protective effects (Michael et 
al., 2001; Hinson et al., 2002). 
 The report of Fu et al., (2001) of GPx1 knockout protection against PN 
induced cell death in murine hepatocytes needs further in vivo investigation. 
Unfortunately, PN is too reactive to be used directly in animals. The putative 
role of PN in AP toxicity provides a way to increase RNS in an animal. In 
addition, the role of superoxide production in AP toxicity gives a further 
dimension to the question involving ROS, since mice lacking functional GPx1 
or SOD1 have greatly increased ROS sensitivity (Cheng et al., 1998b; Ho et 
al., 1998). Given the importance of SOD1 and GPx1 in protecting against ROS 
and the resistance of GPx1 knockout cells to PN, how might the deletion of 
another antioxidant protein (SOD1) affect these responses? In this study, we 
examined the effects of various gene dosages of GPx1 and SOD1 in mice on 
diquat toxicity (an in vivo ROS generator) and AP toxicity (as a putative in vivo 
RNS producer).  
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Protocols 
A total of 71 mice with various copy numbers of GPx1 and SOD1 genes 
were treated with intraperitoneal injections of 25 mg/kg body weight diquat 
(DQ), 600 mg/kg body weight acetaminophen (AP) or phosphate buffered 
saline (PBS) as control (see Table 4.1 for experimental group descriptions). 
Mice were fasted for 8 h before injection and given free access to food and 
water after injection and throughout the trial., Wild-type mice 
(GPx1+/+|SOD1+/+ [n = 6]) were included only in survival analysis and 
excluded from biochemical analyses. Mice were observed for 72 h post-
injection and upon death, samples of liver and plasma were collected for 
GPx1, SOD and ALT activity assays. Time of death was recorded for all mice. 
All surviving mice were sacrificed at 72 h post-injection and the same samples 
collected. Plasma samples (from n = 69 mice) were used fresh for ALT activity 
assay. Liver samples (from n = 61 mice) were snap frozen in liquid nitrogen 
and stored at -80°C until homogenized for GPx1 and SOD activity assays. 
Survival was analyzed using a general linear model for main effects and 
Scheffe’s test for mean comparisons. Further survival analysis compared 
models from Cox proportional hazards analysis. Enzyme assays were 
analyzed using a general linear model for main effects and Tukey’s test for 
mean comparisons. See Materials and Methods (Chapter 2) for a more 
detailed description of statistical analyses. 
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Table 4.1. Experimental groups in 72 h survival trial by GPx1 genotype, SOD1 
genotype and treatment. 
 
AP = 600 mg acetaminophen /kg body weight; DQ = 25 mg diquat /kg body 
weight; PBS = phosphate buffered saline; + =  wild type allele;  -  =  knockout 
allele 
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Results 
All mice treated with PBS survived. Overall, 26.7% (n = 19 out of n = 
71) mice from 5 of the 16 groups died within the 72 h observation period. 
Samples were not immediately collected from two mice which died and have 
therefore been excluded from all biochemical analyses but were included in 
survival analyses.  
 
Survival: SOD1 Effects 
AP-treated SOD1+/+ mice had a significantly lower survival time than 
SOD1+/- or SOD1-/- mice when compared within a general linear model (<20 
h vs. >40 h and >72 h P < 0.05). DQ treatment showed the opposite effect: 
SOD1 -/- mice died within 20 hours but SOD1+/+ survived the entire 72 h 
observation period. When compared between treatments, SOD1-/- mice 
survived AP treatment but died in <20 h with DQ treatment and although the 
difference is non-significant in the general linear model, SOD1+/+ mice 
showed decreased survival when treated with AP and full survival with DQ 
treatment (Figure 4.1). Although the data could not be adjusted for the effect of 
the GPx1 genotype due to limitations of the size of the study, SOD1 
genotype*Treatment survival curves of the experimental data show that DQ-
treated SOD1 -/- mice had a rapid decline in survival while all DQ-treated 
SOD1+/+ mice survived the entire trial and SOD1+/- had survival rates 
intermediate between the two.  The experimental data survival curves also 
show that with AP treatment SOD1+/+ had the greatest decline in survival, all 
SOD1-/- survived and SOD1+/- had survival rates between the two  (Figure 
4.2). 
Effects of SOD1 genotype independent of GPx1 genotype were 
analyzed with Cox Proportional Hazards (CPH) models stratified for GPx1. A 
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model for AP survival time which showed significant correlation with 
experimental AP effect on SOD1 genotypes was based on a full description of 
the SOD1 genotype [SOD1(-) copy number*SOD1(+) copy number*AP], 
stratified for a full description of the GPx1 genotype [GPx1(-) copy 
number*GPx1(+) copy number]. In this model, SOD1-/- mice had no AP-
induced mortality and mice possessing one or both functional copies of SOD1 
(SOD1+/- or SOD1+/+) had decreased survival rates (68% and 19% survived 
to 72 h, respectively) (Figure 4.3). 
A CPH model with significant correlation to the experimental data for 
the response of SOD1 genotypes to DQ treatment is based on SOD1(-) copy 
number*DQ stratified by either GPx1(-)copy number. This model shows that 
absence of one or both copies of SOD1 (SOD1+/- or SOD1-/-) is associated 
with a precipitous decrease in survival rate (100% of SOD-/- and >50% of 
SOD+/- died before 20 h while SOD1+/+ mice survived the entire DQ trial 
(Figure 4.3). 
 
Survival: GPx1 Effects 
 When compared within general linear models, only DQ-treated GPx1-/- 
mice had a significantly shorter survival time (<20 h) than any other GPx1 
genotype*Treatment groups (P < 0.05, Figure 4.1).  Due to small sample size, 
these general linear models could not be adjusted for effects of SOD1 
genotype.  
Examination of GPx1 genotype*Treatment experimental data survival curves 
show that with either AP or DQ treatment GPx1-/- mice had the most rapid 
decline of survival, all GPx1+/+ mice survived and GPx1+/- mice had survival 
rates intermediate between the two. As noted above, these data were not 
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Figure 4.1. Effect of GPx1 or SOD1 genotype in mice on 72 h survival of 
acetaminophen or diquat treatment. Diquat treated SOD1-/- and GPx1-/- mice 
had significantly shorter survival than other mice. Although there were no 
significant differences, SOD1+/+ and GPx1-/- mice show a trend towards 
decreased survival., Values are means ± SEM (n = 3-16). Bars with different 
letters are significantly different at P < 0.05.  
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 adjusted for the effect of the other genotype due to the limitations of study 
size (Figure 4.2). 
 In order to separate effects of GPx1 genotype from SOD1 genotype, 
data were analyzed using CPH models stratified for SOD1. These models are 
based on interaction of GPx1(+) copy number with treatment stratified by 
SOD1(+) copy number and show significant correlation with the experimental 
data survival curves (P < 0.05).  In agreement with the experimental data, 
these models show that both AP- and DQ-treated GPx1-/- and GPx1+/- have 
decreased survival rates when compared with GPx1+/+ (Figure 4.4). 
 
Survival: GPx1 – SOD1 Interactions 
In the time categorized general linear model, mice with only one 
functional copy in total of both GPx1 and SOD1 (i.e. GPx1+/-|SOD1-/- or 
GPx1-/-|SOD1+/-) had significantly shorter survival time when treated with DQ 
than mice carrying more than one functional copy in total or PBS control (0-20 
h versus >20 h, P < 0.05).  Survival of mice with these same genotypes 
(GPx1+/-|SOD1-/- and GPx1-/-|SOD1+/-) treated with AP was not significantly 
different from control (>72 h). In comparison with PBS control, GPx1+/-
|SOD1+/+ mice had significantly shorter survival time when treated with AP 
but had no change with DQ treatment (<20 h versus >72 h, P < 0.05).  Mice 
with one functional copy of each gene (GPx1+/-|SOD1+/-) showed no 
difference in survival from control (>72 h versus >72 h) when treated with 
either DQ or AP (Table 4.2). From the survival curves of the experimental 
data, it can be seen that mice with the smallest number of functional copies of 
GPx1 and SOD1 (i.e. GPx1-/-|SOD1+/- and GPx1+/-|SOD1-/-) treated with DQ  
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Figure 4.3. Seventy-two hour survival curves from Cox proportional hazards 
models of mice with various gene dosages of GPx1 and SOD1 treated with 
acetaminophen or diquat: SOD1*treatment effects. A Cox proportional hazards 
model showing high correlation (P < 0.05) with experimental SOD1 genotype 
response to acetaminophen is based on a full description of the SOD1 
genotype stratified for a full description of the GPx1 genotype. The AP model 
shows that SOD1-/- mice survive acetaminophen treatment while SOD1+/+ 
mice die rapidly. A Cox proportional hazards model showing high correlation 
(P < 0.05) with experimental SOD1 genotype response to Diquat is based on 
SOD1(-) copy number stratified for GPx1(+) copy number. The DQ model 
shows that SOD1-/- mice die rapidly with diquat treatment and SOD1+/+ mice 
survive. KO = -/- , Het = +/-, WT = +/+. 
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Figure 4.4. Seventy-two hour survival curves from Cox proportional hazards 
models of mice with various gene dosages of GPx1 and SOD1 treated with 
acetaminophen or diquat: GPx1*treatment effects.A Cox proportional hazards 
models showing high correlation (P < 0.05) with experimental GPx1 genotype 
response to acetaminophen or diquat is based on GPx1(-) copy number 
stratified for SOD1(+) copy number. The AP model shows that GPx1-/- mice 
have decreased survival with acetaminophen treatment while GPx1+/+ mice 
survive. Similarly, the DQ model shows that GPx1-/- mice die rapidly with 
diquat treatment and SOD1+/+ mice survive. KO = -/- , Het = +/-, WT = +/+. 
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Table 4.2 Effect of various dosages of GPx1(-) and SOD1(-) in mice on 72 h 
survival of acetaminophen or diquat treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Values are expressed as means ± SEM (n = 3-6). Values not sharing a 
common letter are significantly different at P < 0.05. Survival classes:  
1 = <20 h; 2 = 20-40 h; 3 = 40-<72 h; 4 = >72 h. 
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had the steepest decrease in survival rate. Among AP treated mice, GPx1+/-
|SOD1+/+ and GPx1-/-|SOD1+/- had the largest decrease in survival. A CPH 
model based on GPx1(-) copy number*SOD1(-) copy number*treatment 
(Figure 4.5) shows significant correlation with the experimental data but group 
sizes and survival rates preclude making statistically significant conclusions. 
 
Biochemical Analyses 
Plasma ALT: Time of death and treatment had significant effects on plasma 
ALT, a measure of liver toxicity. All mice that survived to the end of the 
experiment showed no significant change in ALT from PBS control. Mice who 
died in less than 20 hours of AP- or DQ- treatment showed significant 
increases in ALT compared with those that survived the injections (>72 h) and 
PBS control (3145 ± 877 and 2129 ± 537 versus 152 ± 368 U/L, respectively; 
P < 0.05). AP-treated mice who died between 20 - 40 h and 40 - >72 h had 
significant increases in ALT over control: (11740 ± 1074 and 6297 ± 1074 
versus 152 ± 368 U/litre P < 0.05). DQ treated mice that died during the same 
time period had no significant ALT increases. (Figure 4.6).  
 
GPx1 Activity 
GPx1 genotype and SOD1 genotype both had significant effects on 
liver GPx1 activity. All GPx1+/- and GPx1-/- mice showed significantly lower 
liver GPx1 activity than GPx1+/+ mice (from 1 ± 32 to 553 ± 30 versus 1014 ± 
36 U/mg protein, P < 0.05). Among GPx1+/- mice, those with SOD1-/- showed 
significantly lower liver GPx1 activity than those with SOD1+/- (364±40 versus 
553 ± 30 U/mg protein, P < 0.05) and marginally lower activity than those with 
SOD1+/+ (364 ± 40 versus 504 ± 36 U/mg protein, P=0.0778). Treatment and 
survival time did not significantly affect liver GPx1 activity (Figure 4.7).   
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Figure 4.5. Seventy-two hour survival curves from experimental data and a 
Cox proportional hazards model of mice with various gene dosages of GPx1 
and SOD1 treated with acetaminophen or diquat: GPx1, SOD1 and treatment 
effects. A Cox proportional hazards model that shows high correlation (P < 
0.05) with experimental data is based on GPx1(-) copy number, SOD1(-) copy 
number and treatment. S=SOD1, G=GPx1, KO = -/- , Het = +/-, WT = +/+ 
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Figure 4.6. Plasma alanine aminotransferase activity in mice with various 
gene dosages of GPx1 and SOD1 treated with acetaminophen or diquat: 72 h 
survival study. ALT activity peaked at <20 h survival in DQ treated mice and at 
20-40 h survival in AP treated mice. All mice that survived 72+ h had normal 
ALT activity. Values are expressed as means ± SEM (n = 9-24). Values not 
sharing a common letter are significantly different at P < 0.05. 
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Figure 4.7. Liver GPx1 activity in mice with various gene dosages of GPx1 
and SOD1: Gene dosage effects. GPx1-/- mice had negligible activity. All 
GPx1+/- had lower activity than GPx1+/+ mice.  SOD1 genotype had an effect 
on GPx1 activity GPx1+/- mice had 34% and 28% reductions in liver GPx1 
activity, depending on SOD1(-) copy number when compared with SOD1+/+. 
Values are expressed as means ± SEM (n = 7-16). Values not sharing a 
common letter are significantly different at P < 0.05. Values that share C are 
different at P = 0.0778.  
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A general linear model of liver GPx1 activity demonstrates this significant (P < 
0.01) relationship between GPx1 activity and SOD1 genotype. Based on its R2 
value, this model accounts for over 89% of variability of liver GPx1 activity in 
this experiment (Figure 4.8). 
 
SOD Activity 
SOD1 genotype had the most significant effects on liver SOD activity. 
All SOD1 -/- mice had negligible activity (<25 units/mg protein) and PBS 
treated SOD1+/- mice had significantly lower activity than SOD1+/+ mice (P < 
0.05, data not shown).  
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Figure 4.8. Correlation of general linear model prediction of GPx1 activity with 
experimental data based on GPx1 genotype and SOD1 genotype. A general 
linear model of liver GPx1 activity based on GPx1 genotype and GPx1*SOD1 
genotype interaction is highly correlated with experimental GPx1 activity. This 
model accounts for nearly 90% of variation seen in the experimental data and 
describes a negative correlation between the SOD1(-) gene and GPx1 activity 
in the liver. 
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Discussion 
 This study has provided evidence of opposite effects of certain gene 
dosages of GPx1 and SOD1 in mice on survival of acetaminophen (AP) 
treatment and diquat (DQ) treatment. In this study, both raw survival curves 
based on experimental data and general linear models are flawed when GPx1 
and SOD1 are considered separately. Small sample sizes and group survival 
rates preclude adjusting the effect of one gene for the effect of the other. We 
therefore believe that this has skewed some survival times and influenced 
interpretation of results. However, by use of stratified analyses, Cox 
proportional hazards (CPH) models were able to separate the survival curves 
of each gene. Sample size has also limited interpretation of CPH analysis 
since confidence intervals could not be calculated with such small numbers of 
observations.  Primarily, we have based our analyses of individual gene 
effects on survival on correlation of CPH models with experimental data. 
General linear models provide some support for our interpretation of CPH 
models.  
 When the gene effects are separately analyzed in stratified CPH 
models, the data show that both SOD1-/- and GPx1-/- mice die rapidly with 
DQ treatment (<20 h). However, SOD1-/- mice survive AP treatment (>72 h) 
while GPx1-/- mice have a greatly decreased survival rate (majority die by 72 
h). This shows the opposite effects that SOD1(-), but not GPx1(-), had on AP 
and DQ survival. 
  Opposite effects on DQ and AP survival were also seen when both 
GPx1 and SOD1 genotype were considered together. When treated with AP, 
mice with only one functional copy in total of GPx1 and SOD1 (GPx1+/-
|SOD1-/- or GPx1-/-|SOD1+/-) survived the entire trial (>72 h). Conversely, 
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mice with the same genotypes died significantly earlier than control (<20 h) 
when treated with DQ.  
 When mice with only one allelic knockout in total of GPx1 and SOD1 
(GPx1+/+|SOD1+/- or GPx1+/-|SOD1+/+) were examined, another interaction 
between these genes and treatments emerged. AP-treated GPx1+/-|SOD1+/+ 
mice died in less than 40 h (P < 0.05, compared with control) but AP-treated 
GPx1+/-|SOD1+/- survival time was not significantly different from control (>72 
h). Since the difference between these genotypes is SOD1 copy number, 
SOD1(-) appears to have had a greater influence on AP survival than GPx1(-). 
 Our DQ treatment results are consistent with previous work on GPx1 
knockout and SOD1 knockout mouse models (Cheng et al., 1998b; Ho et al., 
1998) and the in vivo anti-oxidative functions of these proteins.  However, our 
results are not entirely consistent with hypotheses of ROS and PN 
involvement in AP toxicity. It has been reported that AP metabolism produces 
superoxide and that exogenous SOD is able to protect against AP toxicity (Dai 
and Cederbaum, 1995; Nakae et al., 1990). Contrary to this, our results 
suggest that SOD1-/- mice, which have less protection against superoxide 
damage, are more resistant to AP toxicity. Since GPx1(-) increases sensitivity 
to AP toxicity, our results are consistent with PN production by AP and GPx1 
participation in its detoxification (Hinson et al., 1998; Knight et al., 2001; Knight 
and Jaeschke, 2004). However, our findings are not consistent with the 
hypothetical role of superoxide in AP induced PN production. If it is assumed 
that SOD1-/- mice have a decreased ability to metabolize superoxide and 
therefore have a higher intracellular superoxide concentration, PN production 
and AP toxicity should be increased.  Our experiments do not support this. 
Established hypotheses of AP toxicity may be incomplete or there may be 
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certain changes in AP metabolism related to SOD1(-) but not GPx1(-) which 
alter AP toxicity. 
 Aside from effects on survival, this study found a strong effect of 
SOD1(-) on GPx1 activity. When GPx1+/- mice with three different copy 
numbers of SOD1 were compared, we found that SOD1-/- mice had 72% (P < 
0.05) and 66% (P = 0.0778) of SOD1+/- and SOD1+/+ liver GPx1 activity, 
respectively. Some work has indicated that GPx1 expression and activity can 
be regulated by changes in cellular oxygen tension (Cowan et al., 1993; Cao 
et al., 2003) and although it is reasonable to assume that SOD1(-) leads to 
these types of changes, we do not have evidence at this time to support such 
an hypothesis. Among PBS treated mice, SOD1 genotype was also highly 
correlated with liver SOD1 activity as follows: SOD-/- < SOD +/- < SOD +/+ (P 
< 0.05, data not shown).  
 We have used plasma ALT as an indicator of liver toxicity. Although 
there was not a highly significant effect of genotype on plasma ALT, treatment 
and survival time did have significant effects. According to models discussed 
above, treatment and survival time are related by genotype, therefore we 
believe genotype has an influence on these results.  According to our ALT 
data, hepatocellular AP damage apparently peaks between 20 and 40 h while 
ALT of DQ-treated mice peaks at <20 h. Both AP and DQ liver injury recover 
to normal levels by 72 h. We suspect that these differences are due to the 
mechanisms of lethality of AP and DQ and how they may change over time. 
With a larger sample size, it would be interesting to outline the progression of 
ALT activity changes in these mice with various dosages of GPx1 and SOD1 
in order to explore possible differences in lethality mechanisms. Earlier death 
(<20 h) may be due to loss of reducing equivalents (Cheng et al., 1999) while 
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later death (and ALT increases) may be due to hepatocellular injury (Cheng et 
al., 2003). 
In summary, this study has shown that SOD1(-) is associated with 
decreased sensitivity to AP toxicity, increased sensitivity to DQ toxicity and 
decreased liver GPx1 activity. In contrast, GPx1(-) is associated with 
increased sensitivity to both AP and DQ toxicity. Based these results, we 
suggest that AP metabolism is changed in mice with SOD1(-). In addition, the 
temporal progression of hepatotoxicity may have been altered by changes in 
GPx1 and SOD1 gene copy number. 
 
CHAPTER 5: 
SUMMARY AND CONCLUSIONS 
 Knockout mouse models of antioxidant proteins provide a powerful tool 
to investigate the physiological functions of these proteins. Previously, work 
with whole animal research models on the selenoperoxidases and Cu,Zn-
dependent superoxide dismutase was limited to nutritionally deficient models. 
These models could not be used to specifically address the effect of one 
protein without involvement of many other factors. Many questions remain to 
be addressed in whole animal models due to the limitations of these older 
methods. This thesis addresses the effects of altered gene dosage on 
antioxidant protein expression and sensitivity to xenobiotics. 
 The haploid insufficient model of GPx4 provides the first opportunity to 
independently test effects of reduced GPx4 activity. Selenium deficiency 
causes a number of physiological changes, including male reproductive 
dysfunction and increased pro-oxidant sensitivity that may be mediated 
through GPx4. Although a haploid insufficent model is not ideal for these 
investigations, it can provide insight into the physiological function of GPx4. 
 Previous work in our lab has shown that reduction of antioxidant 
enzyme activity is not always detrimental., We have found that GPx1 knockout 
decreased hepatocyte sensitivity to peroxynitrite (RNS) while increasing 
hepatocyte and whole animal ROS sensitivity (Cheng et al., 1998b; Fu et al., 
2001).  The GPx1 knockout-mediated changes in RNS sensitivity remained to 
be tested in whole animals. This question was expanded to include effects of 
another important antioxidant protein, SOD1, using knockout mouse models to 
specifically address the effect of various combinations of GPx1 and SOD1 
gene dosage on ROS and RNS sensitivity and GPx1 and SOD activity. 
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Experiment 1 found that deletion of one copy of GPx4 resulted in a 24-
39% reduction in GPx4 activities in liver, lung, kidney, and testes, compared 
with WT mice (P < 0.05).  GPx1 activities in various tissues and GPx3 
activities in plasma were unaffected by the GPx4 knockout therefore these 
selenoperoxidases have expression that is independent of GPx4. 
The testes exhibited the highest percentage change in GPx4 activity in 
response to the gene knockout. However, since the knockout of one allele of 
gpx4 did not lead to 50% activity reduction in the assayed tissues, as in some 
cases of gene knockout (Huang et al., 1996; Kline et al., 2002; Hattori et al., 
2005), expression of the remaining allele may have been up-regulated to 
compensate for the deletion. In addition, testes showed the only significant 
change in tissue selenium concentration in GPx4+/- (34% reduction compared 
with WT mice, P > 0.05).  
 
Experiment 1: 
1. GPx4+/- mice had 24 - 39% reduction in GPx4 activity in lung, liver, 
kidney and testes 
2. GPx4+/- did not significantly affect susceptibility to paraquat induced 
protein carbonyl formation 
3. GPx4+/- did not affect GPx1 or GPx3 activity 
4. GPx4+/- testis had a 34% reduction in selenium concentration 
 
 Experiment 2 provided evidence of opposite effects of certain gene 
dosages of GPx1 and SOD1 in mice on lethality of acetaminophen and diquat  
toxicity. Sample size has limited interpretation of statistical analyses but some 
significant effects and some general trends emerged.  SOD1-/- and GPx1-/- 
mice both die rapidly with DQ treatment (<20 h, P < 0.05). However, SOD1-/- 
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mice survive AP treatment (>72 h) while GPx1-/- mice have a greatly 
decreased survival rate (majority die by 72 h), demonstrating opposite effects 
of SOD1(-), but not GPx1(-), on AP and DQ lethality.  
 Similar effects emerged when these two genes were considered in 
combination. Mice with only one functional copy in total of GPx1 and SOD1 
(GPx1+/-|SOD1-/- or GPx1-/-|SOD1+/-) died significantly earlier than control 
(<20 h, P<0.05) when treated with DQ but survived the entire trial when 
treated with AP (>72 h).  
 Mice with only one knockout in total of GPx1 and SOD1 
(GPx1+/+|SOD1+/- or GPx1+/-|SOD1+/+) had responses that further 
supported our hypotheses. AP-treated GPx1+/-|SOD1+/+ mice died 
significantly earlier than control (<40 h, P < 0.05) but AP-treated GPx1+/-
|SOD1+/- survival was not significantly different from control (>72 h). Since a 
change in SOD1 copy number led to this difference, we speculate that  
SOD1(-) had a greater influence on AP survival than GPx1(-). The sensitivity 
of mice lacking functional GPx1/SOD1 copies to DQ treatment is consistent 
with previous work on GPx1 knockout and SOD1 knockout mouse models 
(Cheng et al., 1998b; Ho et al., 1998).  Our results do not support those of 
Nakae et al., (1990) who reported that AP toxicity is partly due to superoxide 
production. Mice with SOD1(-) were more resistant to AP toxicity, even though 
they are less resistant to the superoxide generator, diquat. Since we found 
that GPx1(-) increased sensitivity to AP toxicity, our results are consistent with 
PN production by AP and GPx1 participation in PN detoxification (Hinson et 
al., 1998; Knight et al., 2001; Knight and Jaeschke, 2004) but do not provide 
supportive evidence. 
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  A strong effect of SOD(-) on GPx1 activity was found. When mice with 
three different copy numbers of SOD1 were compared, liver GPx1 activity was 
reduced by as much as 34% compared with SOD1+/+ mice.  
 Finally, according to our ALT data, hepatocellular AP damage 
apparently peaks between 20 and 40 h while ALT of DQ-treated mice peaks at 
<20 h. All ALT activities returned to normal by 72 h. We suspect that these 
differences may be due to the mechanisms of AP and DQ lethality and how 
they change over time. 
 
Experiment 2: 
1. SOD1(-) made mice more susceptible to diquat lethality 
2. SOD1(-) made mice less susceptible to acetaminophen lethality 
3. GPx1(-) made mice more susceptible to both diquat and 
acetaminophen lethality 
4. SOD(-) can rescue mice with GPx1(-) from acetaminophen lethality 
5. SOD+/- and SOD -/- mice have 28% - 34% lower GPx1 activity 
6. SOD(-) and GPx1(-) alter the progression and severity of diquat and 
acetaminophen hepatotoxicity 
 
  In conclusion, the deletion of one allele of GPx4 resulted in differential 
changes in GPx4 activities and selenium concentrations in lung, liver, kidney 
and testis. However, GPx4+/- mice showed no increased susceptibility to 
protein oxidation mediated by moderate oxidative stress and no apparent 
deficit in reproduction. SOD1(-) is associated with decreased sensitivity to AP 
toxicity, increased sensitivity to DQ toxicity and decreased liver GPx1 activity 
while GPx1(-) is associated with increased sensitivity to both AP and DQ 
toxicity. Based on these results, we suggest that AP metabolism and the 
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temporal progression of AP and DQ hepatotoxicity have been altered by 
changes in GPx1 and SOD1 gene copy number.  
 
Future Directions of Research 
 The usefulness of the GPx4 haploid insufficient model is limited by its 
intact GPx4 allele. Taking Experiment 1 as an example, the function of the 
remaining GPx4 allele is sufficient for apparently normal physiological function. 
A full GPx4 knockout would be a very powerful model for research into its 
physiological role and embryonic lethality of the GPx4 nullizygous mouse may 
no longer be a limitation to production of this model. By avoiding a whole body 
knockout or delaying activation of the knockout until the mouse is mature, 
tissue specific and inducible gene knockouts based on the Cre/Lox system 
may provide a way to produce a true GPx4 knockout mouse (for review of 
Cre/Lox, see Sauer, 1998). 
  The production of a Cre/Lox GPx4 mouse in which the knockout can be 
induced once the animal has reached adulthood will be an important step 
forward in the study of GPx4 function. If this model is non-viable, cause of 
death alone would provide some important insight into the role of GPx4. In that 
case, testis, brain, liver, lung, kidney and muscle-specific GPx4 knockouts 
would be the alternate means of studying the still unclear physiological 
function of GPx4. 
 In Experiment 2, two very interesting observations stood out: 1) 
resistance to acetaminophen toxicity in SOD1 knockout mice and 2) decrease 
of GPx1 activity in SOD1 knockout liver.  
 The future of research into altered AP toxicity is in examining its 
mechanism. Is production of toxic metabolites changed? Is SOD1 directly 
involved in AP metabolism or do other changes account for this? Is the means 
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of detoxification of toxic metabolites changed? Could changes in superoxide 
concentration in the cell make those metabolites less toxic? Is clearance of the 
drug altered? How does SOD1 knockout affect drug clearance? These 
questions, and many more, open research possibilities in both drug 
metabolism and oxidative stress. 
In the case of decreased GPx1 activity in SOD(-) mice, mechanism is 
again the key. If there is less GPx1, it may be due to increased degradation of 
GPx1 or a control on expression which is sensitive to its substrate, hydrogen 
peroxide. Oxidative damage to GPx1 due to altered cellular redox status may 
account for enhanced degradation. If the amount of GPx1 is unchanged, how 
is its activity being post-translationally regulated? Is this regulation sensitive to 
cellular redox status? Does this altered activity serve a physiological purpose? 
These avenues of research may lead in new directions for investigation of 
redox regulation of enzyme activity and the interdependency of antioxidant 
enzymes. 
 
Bibliography 
 
1. Allan CB, Lacourciere GM, Stadtman TC. Responsiveness of 
selenoproteins to dietary selenium. Annu Rev Nutr 1999.19:1–16  
2. Allison PD. Survival Analysis Using SAS: A Practical Guide. SAS 
Publishing. Cary, NC. 1995 
3. Arai M, Imai H, Sum, D, Imanaka T, Takano T, Chiba N, Nakagawa Y. 
Import into mitochondria of phospholipid hydroperoxide glutathione 
peroxidase requires a leader sequence. Biochem Biophys Res 
Commun 1996. 227:433–439 
4. Avissar N, Finkelstein JN, Horowitz S, Willey JC, Coy E, Frampton MW, 
Watkins RH, Khullar P, Xu YL, Cohen HJ.  Extracellular glutathione 
peroxidase in human lung epithelial lining fluid and in lung cells. Am J 
Physiol 1996. 270:L173-82. 
5. Behne D, Weiler H, Kyriakopoulos A.  Effects of selenium deficiency on 
testicular morphology and function in rats. J Reprod Fertil 
1996.106:291-297  
6. Benedetto, M T, Anzai Y,Gordon J W. Isolation and analysis of the 
mouse genomic sequence encoding Cu-Zn superoxide dismutase. 
Gene 1991. 99:191–195 
7. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and 
oxidative stress. J Biol Chem 1997. 272:20313–20316 
8. Bermano G, Nicol F, Dyer JA, Sunde RA, Beckett GJ, Arthur JR, 
Hesketh JE. Selenoprotein gene expression during selenium-repletion 
of selenium-deficient rats. Biol Trace Elem Res 1996. 51:211-223  
9. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, Larsen 
PR. Recognition of UGA as a selenocysteine codon in type I deiodinase 
requires sequences in the 30 untranslated region. Nature (London) 
1991. 353:273–276 
71 
 72
10. Berry MJ, Banu L, Larsen PR. Type 1 iodothyronine deiodinase is a 
selenocysteine-containing enzyme, Nature (London) 1991. 349, 438 
11. Berry MJ, Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Martin 
GW 3rd, Low SC, Mansell JB, Grundner-Culemann E, Harney JW, 
Driscoll DM, Hatfield DL. Selenocysteine incorporation directed from the 
3'UTR: characterization of eukaryotic EFsec and mechanistic 
implications. Biofactors. 2001.14:17-24 
12. Bismuth C, Scherrmann JM, Garnier R, Baud FJ, Pontal PG.  
Elimination of paraquat. Dev Toxicol Environ Sci 1986. 12:347-356 
13. Bjornstedt M, Xue J, Huang W, Akesson B, Holmgren A. The 
thioredoxin and glutaredoxin systems are efficient electron donors to 
human plasma glutathione peroxidase. J. Biol. Chem 1994. 269:29382– 
29384 
14. Bock A. Selenium metabolism in bacteria. In: Hatfield DL, ed. 2001. 
Selenium. Its Molecular Biology and Role in Human Health. Boston: 
Kluwer., pp. 2–22 
15. Brigelius-Flohe R. Tissue-specific functions of individual glutathione 
peroxidases. Free Radic Biol Med 1999. 27:951– 965  
16. Bruijn, L. I, Houseweart, M. K, Kato, S, Anderson, K. L, Anderson, S. D, 
Ohama, E, Reaume, A. G, Scott, R. W, Cleveland, D. W. Aggregation 
and motor neuron toxicity of an ALS-linked SOD1 mutant independent 
from wild-type SOD1. Science 1998. 281:1851–1854 
17. Burk RF, Hill KE, Awad JA, Morrow JD, Kato T, Cockell KA, Lyons PR.  
Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: 
assessment of the roles of lipid peroxidation and selenoprotein P. 
Hepatology 1995. 21:561-569.  
18. Burk RF, Hill KE.  Regulation of selenoproteins. Annu Rev Nutr 
1993.13:65-81 
19. Burk RF, Lawrence RA, Lane JM. Liver necrosis and lipid peroxidation 
in the rat as the result of paraquat and diquat administration. Effect of 
selenium deficiency. J Clin Invest 1980. 65:1024-1031 
 73
20. Burk RF.  Molecular biology of selenium with implications for its 
metabolism. FASEB J 1991. 5:2274-2279. 
21. Bus JS, Aust SD, Gibson JE. Superoxide- and singlet oxygen-catalyzed 
lipid peroxidation as a possible mechanism for paraquat (methyl 
viologen) toxicity. Biochem Biophys Res Commun 1974. 58:749-755 
22. Bus JS, Cagen SZ, Olgaard M, Gibson JE.  A mechanism of paraquat 
toxicity in mice and rats. Toxicol Appl Pharmacol 1976. 35:501-513 
23. Cagen SZ, Gibson JE.  Liver damage following paraquat in selenium-
deficient and diethylmaleate-pretreated mice. Toxicol Appl Pharmacol 
1977. 40:193-200 
24. Carlson BA, Martin-Romero FJ, Kumaraswamy E, Moustafa ME, Zhi H, 
Hatfield DL, Lee BJ. Mammalian selenocysteine tRNA, p. 23–32. In: D. 
L. Hatfield (ed.) Selenium: its molecular biology and role in human 
health. Kluwer Academic Publishers, Norwell, MA 2001 
25. Cao C, Leng Y, Huang W, Liu X, Kufe D. Glutathione peroxidase 1 is 
regulated by the c-Abl and Arg tyrosine kinases. J Biol Chem 2003. 
278:39609-39614 
26. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, Harrison PR.  
The structure of the mouse glutathione peroxidase gene: the 
selenocysteine in the active site is encoded by the 'termination' codon, 
TGA. EMBO J 1986. 5:1221-1227 
27. Chang LY, Slot, J W, Geuze HJ, Crapo JD. Molecular 
immunocytochemistry of the CuZn superoxide dismutase in rat 
hepatocytes. J Cell Biol 1988.107:2169–2179  
28. Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, 
and Nelson SD Oxidation of acetaminophen to its toxic quinone imine 
and nontoxic catechol metabolites by baculovirus-expressed and 
purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol 
1998. 11:295–301 
29. Cheng WH, Ho YS, Ross DA, Han Y, Combs GF Jr, Lei XG.  
Overexpression of cellular glutathione peroxidase does not affect 
 74
expression of plasma glutathione peroxidase or phospholipid 
hydroperoxide glutathione peroxidase in mice offered diets adequate or 
deficient in selenium. J Nutr 1997. 127:675-680 
30. Cheng WH, Combs GF Jr, Lei XG.  Knockout of cellular glutathione 
peroxidase affects selenium-dependent parameters similarly in mice fed 
adequate and excessive dietary selenium. Biofactors 1998a. 7:311-321 
31. Cheng WH, Ho YS, Valentine BA, Ross DA, Combs GF Jr, Lei XG.  
Cellular glutathione peroxidase is the mediator of body selenium to 
protect against paraquat lethality in transgenic mice. J Nutr 
1998b.128:1070-1076  
32. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG.  Selenium-dependent 
cellular glutathione peroxidase protects mice against a pro-oxidant-
induced oxidation of NADPH, NADH, lipids, and protein. FASEB J 
1999.13:1467-1475 
33. Cheng WH, Quimby FW, Lei XG.  Impacts of glutathione peroxidase-1 
knockout on the protection by injected selenium against the pro-
oxidant-induced liver aponecrosis and signaling in selenium-deficient 
mice. Free Radic Biol Med 2003. 34:918-927 
34. Chou, SM, Wang, HS, Taniguchi, A. Role of SOD-1 and nitric 
oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J 
Neurol Sci 1996. 139 (Suppl.):16–26  
35. Chu FF, Doroshow JH, Esworthy RS. Expression, characterization, and 
tissue distribution of a new cellular selenium dependent glutathione 
peroxidase, GSHPx-GI. J Biol Chem 1993.268:2571– 2576  
36. Chu FF, Esworthy RS, Akman S, Doroshow JH. Modulation of 
glutathione peroxidase expression by selenium: effect on human MCF-
7 breast cancer cell transfectants expressing a cellular glutathione 
peroxidase cDNA and doxorubicin-resistant MCF-7 cells. Nucleic Acids 
Res 1990. 18:1531– 1539 
37. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke M M, Wilczynski 
S, Doroshow JH. Bacteria-induced intestinal cancer in mice with 
disrupted Gpx1 and Gpx2 genes. Cancer Res 2004.64:962– 968 
 75
38. Chu FF, Esworthy RS, Ho YS, Bermeister M, Swidere K,  Elliott RW. 
Expression and chromosomal mapping of mouse Gpx2 gene encoding 
the gastrointestinal form of glutathione peroxidase, GPX-GI. Biomed 
Environ Sci 1997. 10:156–162 
39. Cohen HJ, Avissar N. Extracellular glutathione peroxidase: a distinct 
selenoprotein, pg 81-  In: Selenium in Biology and Human Health. Burk 
RF, Ed. Springer-Verlag, New York, NY 1994 
40. Cohen HJ, Chovaniec ME, Mistretta D, Baker SS. Selenium repletion 
and glutathione peroxidase--differential effects on plasma and red blood 
cell enzyme activity. Am J Clin Nutr. 1985. 41:735-747 
41. Compendium of Chemical Terminology The Gold Book, Second Edition 
A. D. McNaught and A. Wilkinson Eds., Blackwell Science, Malden, MA 
1997 
42. Conrad M, Heinzmann U, Wurst W, Bornkamm GW, Brielmeier M. 
Chimeric animals hemizygous for PHGPx show mosaic testicular 
atrophy and abnormal sperm morphology. In: Abstracts of 7th 
International Symposium on Selenium in Biology and Medicine, 
Valencia, Italy; Abstract 34, 2000 
43. Copeland PR, Stepanik VA, Driscoll DM. Insight into mammalian 
selenocysteine insertion: domain structure and ribosome binding 
properties of Sec insertion sequence binding protein 2. Mol Cell Biol 
2001. 21:1491–1498 
44. Copeland PR.  Regulation of gene expression by stop codon recoding: 
selenocysteine. Gene 2003. 312:17-25 
45. Cowan DB, Weisel RD, Williams WG, Mickle DA.  Identification of 
oxygen responsive elements in the 5'-flanking region of the human 
glutathione peroxidase gene. J Biol Chem 1993. 268:26904-26910  
46. Crapo JD, Oury T,  Rabouille C, Slot JW, Chang, L-Y. Copper, zinc 
superoxide dismutase is primarily a cytosolic protein in human cells. 
Proc Natl Acad Sci USA 1992. 89:10405– 10409 
 76
47. Croteau W, Davey JC, Galton VA, St. Germain DL. Cloning of the 
mammalian type II iodothyronine deiodinase. A selenoprotein 
differentially expressed and regulated in human and rat brain and other 
tissues. J Clin Invest 1996. 98: 405  
48. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-Acetyl-p-benzoquinone 
imine: a cytochrome P-450-mediated oxidation product of 
acetaminophen. Proc Natl Acad Sci USA 1984. 81:1327–1331 
49. Dai Y, Cederbaum AI.  Cytotoxicity of acetaminophen in human 
cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 
1995. 273:1497–1505 
50. Daniel JW, Gage JC. Absorption and excretion of diquat and paraquat 
in rats. Br J Ind Med 1966. 23:133-136 
51. de Haan JB, Bladier C, Griffiths P, Kelner M, O'Shea RD, Cheung NS, 
Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, 
Kola I.  Mice with a homozygous null mutation for the most abundant 
glutathione peroxidase, Gpx1, show increased susceptibility to the 
oxidative stress-inducing agents paraquat and hydrogen peroxide. J 
Biol Chem 1998.273:22528-22536 
52. Diamond A, Dudock B, Hatfield D. Structure and properties of a bovine 
liver UGA suppressor serine tRNA with a tryptophan anticodon. Cell 
1981. 25:497–506 
53. Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson 
GJ, Tarpey MM, Barbeito L, Beckman JS. Induction of nitric oxide-
dependent apoptosis in motor neurons by zinc-deficient superoxide 
dismutase. Science 1999.286: 2498–2500  
54. Esworthy RS, Chu FF, Geiger P, Girotti AW, Doroshow JH.  Reactivity 
of plasma glutathione peroxidase with hydroperoxide substrates and 
glutathione. Arch Biochem Biophys 1993. 307:29-34 
55. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu 
FF. Mice with combined disruption of Gpx1 and Gpx2 genes have 
colitis. Am J Physiol Gastrointest Liver Physiol 2001. 281:G848– 855  
 77
56. Esworthy RS, Binder SW, Doroshow JH, Chu FF.Microflora trigger 
colitis in mice deficient in selenium-dependent glutathione peroxidase 
and induce Gpx2 gene expression. Biol Chem 2003. 384:597–607  
57. Esworthy RS, Chu FF, Paxton RJ, Akman S, Doroshow JH. 
Characterization and partial amino acid sequence of human plasma 
glutathione peroxidase. Arch Biochem Biophys 1991. 286:330–336 
58. Esworthy RS, Ho YS, Chu FF. The Gpx1 gene encodes mitochondrial 
glutathione peroxidase in the mouse liver. Arch Biochem Biophys 1997. 
340:59– 63 
59. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 
1998.10:248–253 
60. Flanagan RJ, Braithwaite RA, Brown SS, Widdop B, de Wolff FA.  Basic 
analytical toxicology. World Health Organization, Geneva, Switzerland. 
1995. 
61. Flohe L, Loschen G, Gunzler WA, Eichele E.  Glutathione peroxidase, 
V. The kinetic mechanism. Hoppe Seylers Z Physiol Chem 1972. 
353:987-999. 
62. Flohe L, Wingender E, Brigelius-Flohe R. Regulation of glutathione 
peroxidase. p. 415 In: Oxidative Stress and Signal Transduction. 
Forman HJ and Cadanas, E. Eds. Chapman & Hall, New York, NY  
1997 
63. Flohe, L. The selenoprotein glutathione peroxidase, pg 644 In: 
Glutathione: Chemical, Biochemical and Medical Aspects - Part A. 
Dolphin D, Poulson R, Avramiovic O, Eds., John Wiley and Sons, New 
York, NY. 1989 
64. Flohe L, Gunzler, WA, Schock HH. Glutathione peroxidase: a 
selenoenzyme. FEBS Lett 1973.  32: 132–134 
65. Foresta C, Flohe L, Garolla A, Roveri A, Ursini F, Maiorino M. Male 
fertility is linked to the selenoprotein phospholipid hydroperoxide 
glutathione peroxidase. Biol Reprod 2002. 67:967-971  
 78
66. Fu Y, Cheng WH, Porres JM, Ross DA, Lei XG.  Knockout of cellular 
glutathione peroxidase gene renders mice susceptible to diquat-
induced oxidative stress. Free Radic Biol Med 1999a. 27:605-611 
67. Fu Y, Cheng WH, Ross DA, Lei X.  Cellular glutathione peroxidase 
protects mice against lethal oxidative stress induced by various doses 
of diquat. Proc Soc Exp Biol Med 1999b. 222:164-169 
68. Fu Y, Porres JM, Lei XG.  Comparative impacts of glutathione 
peroxidase-1 gene knockout on oxidative stress induced by reactive 
oxygen and nitrogen species in mouse hepatocytes. Biochem J 2001. 
359:687-695. 
69. Gardner CR., Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge 
GL, Laskin JD, Laskin DL. Role of nitric oxide in acetaminophen-
induced hepatotoxicity in the rat. Hepatology 1998. 26:748-754 
70. Gardner CR, Laskin JD, Dambach DM, Sacco M, Durham SK, Bruno 
MK, Cohen SD, Gordon MK, Gerecke DR, Zhou P, Laskin DL. Reduced 
hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide 
synthase: potential role of tumor necrosis factor-alpha and interleukin-
10. Toxicol Appl Pharmacol 2002. 84: 27-36 
71. Gassmann T. Der Nachweis des Selens im Knochen- und 
Zahngewebe. Hoppe-Seyler’s Z. Physiol Chem 1916. 97:307– 310 
72. Geiger PG, Lin F, Girotti AW.  Selenoperoxidase-mediated 
cytoprotection against the damaging effects of tert-butyl hydroperoxide 
on leukemia cells. Free Radic Biol Med 1993. 14:251-266  
73. Gladyshev VN, Jeang KT, Wootton JC, Hatfield DL.  A new human 
selenium-containing protein. Purification, characterization, and cDNA 
sequence. J Biol Chem 1998. 273:8910-8915 
74. Gmelin-Inst. Anorgan. Chem., ed. Gmelins Handbuch der 
Anorganischen Chemie, Selen, Vol. 1, Part A, p. 24.Weinheim/ Bergstr., 
Ger.:Verlag Chemie. 8th ed. 1953 
 79
75. Gordonsmith RH, Brooke-Taylor S, Smith LL, Cohen GM. Structural 
requirements of compounds to inhibit pulmonary diamine accumulation. 
Biochem Pharmacol 1983. 32:3701-3709 
76. Gromer S, Arscott LD, Williams CH Jr, Schirmer RH, Becker K.  Human 
placenta thioredoxin reductase. Isolation of the selenoenzyme, steady 
state kinetics, and inhibition by therapeutic gold compounds. J Biol 
Chem 1998. 273:20096-20101 
77. Groves CE, Morales MN, Gandolfi AJ, Dantzler WH, Wright SH.  
Peritubular paraquat transport in isolated renal proximal tubules. J 
Pharmacol Exp Ther 1995. 275:926-932 
78. Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H. Mode of cell 
death after acetaminophen overdose in mice: apoptosis or oncotic 
necrosis? Toxicol Sci 2002. 67:322–328 
79. Harris PL, Ludwig MI, Schwarz K.  Ineffectiveness of factor 3-active 
selenium compounds in resorption-gestation bioassay for vit. E. Proc 
Soc Exp Biol Med. 1958. 97:686-688 
80. Hatfield DL, ed. Selenium. Its Molecular Biology and Role in Human 
Health. Boston: Kluwer. 2001. 
81. Hatfield DL, Gladyshev VN.  How selenium has altered our 
understanding of the genetic code. Mol Cell Biol. 2002. 22:3565-3576 
82. Hattori H, Imai H, Hanamoto A, Furuhama K, Nakagawa Y.  Up-
regulation of phospholipid hydroperoxide glutathione peroxidase in rat 
casein-induced polymorphonuclear neutrophils. Biochem J 2005. (in 
press) 
83. Haurand M, Flohe L.  Kinetic studies on arachidonate 5-lipoxygenase 
from rat basophilic leukemia cells. Biol Chem Hoppe Seyler 1988. 
369:133-142 
84. Hayes JD, McLellen LI. Glutathione and glutathione-dependent 
enzymes represent a co-ordinately regulated defence against oxidative 
stress. Free Rad. Res. 1999. 31: 273–300    
 80
85. Hill KE, Lloyd RS, Yang JG, Read R, Burk RF.  The cDNA for rat 
selenoprotein P contains 10 TGA codons in the open readingframe. J 
Biol Chem 1991. 266:10050-10053 
86. Himeno S, Chittum HS, Burk RF.  Isoforms of selenoprotein P in rat 
plasma. Evidence for a full-length form and another form that 
terminates at the second UGA in the open reading frame. J Biol Chem 
1996. 271(26):15769-15775 
87. Hinson JA, Pike SL, Pumford NR, and Mayeux PR. Nitrotyrosine-
protein adducts in hepatic centrilobular areas following toxic doses of 
acetaminophen in mice. Chem Res Toxicol 1998. 11:604–607 
88. Hinson JA, Bucci TJ, Irwin LK, Michael SL, Mayeux PR. Effect of 
inhibitors of nitric oxide synthase on acetaminophen-induced 
hepatotoxicity in mice. Nitric Oxide 2002. 6:160-167. 
89. Ho Y-S, Gargano M, Cao J, Bronson RT, Heimler I, Hutz R. Reduced 
fertility in female mice lacking copper-zinc superoxide dismutase. J Biol 
Chem 1998. 273:7765–7769 
90. Ho Y-S, Magnenat J-L, Bronson RT, Cao J, Gargano M, Sugawara M, 
Funk CD. Mice deficient in cellular glutathione peroxidase develop 
normally and show no increased sensitivity to hyperoxia. J Biol Chem 
1997. 272:16644–16651 
91. Hosmer, Jr DW, Lemeshow S. Applied Survival Analysis: Regression 
Modeling of Time to Event Data. Wiley-Interscience Hoboken, NJ. 1999 
92. Hsu J-L, Visner GA, Burr IA, Nick HS. Rat copper/zinc superoxide 
dismutase gene: isolation, characterization, and species comparison. 
Biochem. Biophys. Res. Commun 1992.186:936–943  
93. Huang HS, Chen CJ, Suzuki H, Yamamoto S, Chang WC. Inhibitory 
effect of phospholipid hydroperoxide glutathione peroxidase on the 
activity of lipoxygenases and cyclooxygenases. Prostaglandins Other 
Lipid Mediat 1999. 58: 65–75 
94. Huang LS, Voyiaziakis E, Chen HL, Rubin EM, Gordon JW.  A novel 
functional role for apolipoprotein B in male infertility in heterozygous 
 81
apolipoprotein B knockout mice. Proc Natl Acad Sci U S A 
1996.93:10903-10907  
95. Imai H, Nakagawa Y.  Biological significance of phospholipid 
hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian 
cells. Free Radic Biol Med 2003. 34:145-169  
96. Imai H, Narashima K, Arai M, Sakamoto H, Chiba N, Nakagawa Y. 
Suppression of leukotriene formation in RBL-2H3 cells that 
overexpressed phospholipid hydroperoxide glutathione peroxidase. J 
Biol Chem 1998. 273:1990–1997  
97. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced 
hepatotoxicity. Drug Metab Dispos. 2003. 31:1499-1506 
98. Jameson RR, Diamond AM A regulatory role for Sec tRNA[Ser]Sec in 
selenoprotein synthesis. RNA. 2004. 10:1142-1152 
99. Kaur H, Halliwell B.  Evidence for nitric oxide-mediated oxidative 
damage in chronic inflammation. Nitrotyrosine in serum and synovial 
fluid from rheumatoid patients. FEBS Lett. 1994. 350:9-12 
100. Kehoe CA, Faughnan MS, Gilmore WS, Coulter JS, Howard AN, Strain 
JJ. Plasma diamine oxidase activity is greater in copper-adequate than 
copper-marginal or copper-deficient rats. J Nutr 2000. 130: 30–33 
101. Keller G-A, Warner TG, Steimer KS, Hallewell RA. Cu,Zn superoxide 
dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma 
cells. Proc Natl Acad Sci USA 1991.88:7381–7385 
102. Keshan Disease Research Group  Epidemiologic studies on the 
etiologic relationship of selenium and Keshan Disease. Chinese 
Medical Journal 1979a. 92: 477-482 
103. Keshan Disease Research Group  Observations on the effect of sodium 
selenite in prevention of Keshan Disease. Chinese Medical Journal 
1979b. 92: 471-476 
 82
104. Kim IY, Guimaraes MJ, Zlotnik A, Bazan JF, Stadtman TC.  Fetal 
mouse selenophosphate synthetase 2 (SPS2): characterization of the 
cysteine mutant form overproduced in a baculovirus-insect cell system. 
Proc Natl Acad Sci U S A. 1997. 94:418-421 
105. Kim HT, Kim YH, Nam JW, Lee HJ, Rho HM, Jung G. Study of 5-
flanking region of human Cu/Zn superoxide dismutase. Biochem 
Biophys Res Commun 1994. 201:1526–1533 
106. Kim YH, Yoo HY, Jung G, Kim JY, Rho HM. Isolation and analysis of 
the rat genomic sequence encoding Cu/Zn superoxide dismutase. 
Gene 1993. 133:267–271 
107. Kirsch M, Lehnig M, Korth HG, Sustmann R, de Groot H.  Inhibition of 
peroxynitrite-induced nitration of tyrosine by glutathione in the presence 
of carbon dioxide through both radical repair and peroxynitrate 
formation. Chemistry. 2001. 7:3313-3320 
108. Kline DD, Peng YJ, Manalo DJ, Semenza GL, Prabhakar NR.   
Defective carotid body function and impaired ventilatory responses to 
chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 
alpha. Proc Natl Acad Sci U S A 2002.99:821-826 
109. Klotz LO, Kroncke KD, Buchczyk DP, Sies H.  Role of copper, zinc, 
selenium and tellurium in the cellular defense against oxidative and 
nitrosative stress. J Nutr. 2003. 133:1448S-1451S 
110. Knight TR, Ho YS, Farhood A, Jaeschke H.  Peroxynitrite is a critical 
mediator of acetaminophen hepatotoxicity in murine livers: protection by 
glutathione. J Pharmacol Exp Ther. 2002. 303:468-475 
111. Knight TR, Jaeschke H.  Peroxynitrite formation and sinusoidal 
endothelial cell injury during acetaminophen-induced hepatotoxicity in 
mice. Comp Hepatol. 2004. 3:S46 
112. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H.  Vascular and 
hepatocellular peroxynitrite formation during acetaminophen toxicity: 
role of mitochondrial oxidant stress. Toxicol Sci. 2001. 62:212-220 
 83
113. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, 
Guigo R, Gladyshev VN.  Characterization of mammalian 
selenoproteomes. Science. 2003. 300:1439-1443  
114. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H.  
Inhibition of Fas receptor (CD95)-induced caspase activation and 
apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 1999. 
156:179–186 
115. Lei XG, Evenson JK, Thompson KM, Sunde RA. Glutathione 
peroxidase and phospholipid hydroperoxide glutathione peroxidase are 
differentially regulated in rats by dietary selenium. J Nutr 1995. 
125:1438-1446 
116. Lei, XG.  Differential regulation and function of glutathione peroxidases 
and other selenoproteins, pp.425-448 In: Nutrient-Gene Interactions in 
Health and Disease Modern Nutrition Series Vol.38 Moustaid-Moussa 
N, Berdanier CD, Eds. CRC  Press, LLC., Boca Raton, FL 2001 
117. Leinfelder W, Zehelein E, Mandrand-Berthelot MA, Bock A. Gene for a 
novel tRNA species that accepts L-serine and cotranslationally inserts 
selenocysteine. Nature 1988. 331:723–725 
118. Levander OA, Ager AL Jr, Beck MA. Vitamin E and selenium: 
contrasting and interacting nutritional determinants of host resistance to 
parasitic and viral infections. Proc Nutr Soc 1995. 54:475-487 
119. Levander OA, Beck MA.  Interacting nutritional and infectious etiologies 
of Keshan disease. Insights from coxsackie virus B-induced myocarditis 
in mice deficient in selenium or vitamin E. Biol Trace Elem Res. 1997. 
56:5-21 
120. Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, 
Bernstein Y, Laver-Rudich Z, Danciger E, Stein O, Groner Y. 
Architecture and anatomy of the chromosomal locus in human 
chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 
1985. 4:77–84  
121. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for 
determination of oxidatively modified proteins. Methods Enzymol 1994. 
233:346-357 
 84
122. Liochev SI, Fridovich I.  Mutant Cu,Zn superoxide dismutases and 
familial amyotrophic lateral sclerosis: evaluation of oxidative 
hypotheses. Free Radic Biol Med. 2003. 34:1383-1389 
123. Liou W, Chang LY, Geuze, HJ, Strous GJ, Crapo JD, Slot JW. 
Distribution of Cu, Zn superoxide dismutase in rat liver. Free Radic Biol 
Med 1993. 14:201–207 
124. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Cobaugh DJ, Youniss J, 
Omslaer JC, May ME, Woolf AD, and Benson BE.  2001 annual report 
of the American Association of Poison Control Centers Toxic Exposure 
Surveillance System. 2002. Am J Emerg Med 20:391–452 
 
125. Liu J, Corton C, Dix DJ, Liu Y, Waalkes MP, Klaassen CD.   Genetic 
background but not metallothionein phenotype dictates sensitivity to 
cadmium-induced testicular injury in mice. Toxicol Appl Pharmacol 
2001. 176:1-9 
126. Locigno R, Castronovo V. Reduced glutathione system: Role in cancer 
development, prevention and treatment. Int J Oncol 2001. 19: 221–236 
127. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement 
with the Folin-Phenol reagents. J Biol Chem 1951. 193: 265-275  
128. Marklund, S. L. Human copper-containing superoxide dismutase of high 
molecular weight. Proc Natl Acad Sci USA 1982. 79:7634– 7638  
129. Marklund SL, Bjelle A, Elmqvist LG. Superoxide dismutase isoenzymes 
of the synovial fluid in rheumatoid arthritis and in reactive arthritides. 
Ann Rheum Dis 1986. 45:847–851 
130. Marklund S L, Holme E, Hellner L. Superoxide dismutase in 
extracellular fluids. Clin. Chim. Acta 1982.126:41–51  
131. Martin GW, Berry MJ. 2001. SECIS elements. pp. 45–54 In: Hatfield 
DL, ed. Selenium. Its Molecular Biology and Role in Human Health. 
Kluwer. Boston, MA 2001 
 85
132. Maser RL, Magenheimer BS, Calvet JP.  Mouse plasma glutathione 
peroxidase. cDNA sequence analysis and renal proximal tubular 
expression and secretion. J Biol Chem. 1994 269:27066-27073 
133. Mates M. Effects of antioxidant enzymes in the molecular control of 
reactive oxygen species toxicology. Toxicology 2000. 153: 83–104 
134. McCord JM, Fridovich I. Superoxide dismutase an enzymic function for 
erythrocuprein (hemocuprein). J Biol Chem 1969. 244:6049-6055 
135. McIlvain VA, Robertson DR, Maimone MM, McCasland JS.  Abnormal 
thalamocortical pathfinding and terminal arbors lead to enlarged barrels 
in neonatal GAP-43 heterozygous mice. J Comp Neurol 2003. 462:252-
264  
136. The Merck Veterinary Manual, Eighth Edition (2003). Eds. Susan E. 
Aiello SE, Mays A; Merck & Co., Inc. Whitehouse Station, NJ. Online 
Version: Eds. Kahn CM, Line S. 
http://www.merckvetmanual.com/mvm/index.jsp 
137. Mercurio SD, Combs GF Jr.  Selenium-dependent glutathione 
peroxidase inhibitors increase toxicity of pro oxidant compounds in 
chicks. J Nutr. 1986a 11:1726-1734  
138. Mercurio SD, Combs GF Jr. Synthetic seleno-organic compound with 
glutathione peroxidase-like activity in the chick. Biochem Pharmacol. 
1986b 35:4505-4509  
139. Michael SL, Mayeux PR, Bucci TJ, Warbritton AR, Irwin LK, Pumford 
NR, Hinson JA. Acetaminophen-induced hepatotoxicity in mice lacking 
inducible nitric oxide synthase. Nitric Oxide 2001. 5:432-441 
140. Mills GC.  Glutathione peroxidase and the destruction of hydrogen 
peroxide in animal tissues. Arch Biochem Biophys. 1960. 86:1-5 
141. Mills GC.  Hemoglobin catabolism. I. Glutathione peroxidase, an 
erythrocyte enzyme which protects hemoglobin from oxidative 
breakdown. J Biol Chem. 1957. 229:189-197 
 86
142. Mills GC.  The purification and properties of glutathione peroxidase of 
erythrocytes. J Biol Chem. 1959. 234:502-506. 
143. Milne DB, Nielsen FH. Effects of a diet low in copper on copper status 
indicators in postmenopausal women. Am J Clin Nutr 1996. 63:358–
364. 
144. Mirault ME, Tremblay A, Beaudoin N, Tremblay M.  Overexpression of 
seleno-glutathione peroxidase by gene transfer enhances the 
resistance of T47D human breast cells to clastogenic oxidants. Biol 
Chem. 1991. 266:20752-20760  
145. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, and Brodie BB  
Acetaminophen-induced hepatic necrosis. IV. Protective role of 
glutathione. J Pharmacol Exp Ther 1973. 187:211–217 
146. Murata M, Gong P, Suzuki K, Koizumi S. Differential metal response 
and regulation of human heavy metal-inducible genes. J Cell Physiol 
1999. 180: 105–113 
147. Muth OH, Oldfield JE, Remmert LF, Schubert JR.  Effects of selenium 
and vitamin E on white muscle disease. Science. 1958. 128:1090 
148. Nakae D, Yoshiji H, Yamamoto K, Maruyama H, Kinugasa T, 
Takashima Y, Denda A, and Konishi YInfluence of timing of 
administration of liposome-encapsulated superoxide dismutase on its 
prevention of acetaminophen-induced liver cell necrosis in rats. Acta 
Pathol Jpn 1990. 40:568–573 
149. Nakamura W, Hosoda S, and Hayachi K Purification and properties of 
rat liver glutathione peroxidase. Biochim Biophys Acta 1974.358:251–
261 
150. Nelson SD Molecular mechanisms of the hepatotoxicity caused by 
acetaminophen. Semin Liver Dis 1990. 10:267–278. 
151. Nomura K, Imai H, Koumura T, Nakagawa Y. Involvement of 
mitochondrial phospholipid hydroperoxide glutathione peroxidase as an 
antiapoptotic factor. Biol. Signals Recept. 2001. 10:81–92  
 87
152. Olson OE, Palmer IS, Cary, EE. Modification of the official fluorometric 
method for Se in plants. J Assoc Off Anal Chem  1975. 58: 117-121  
153. Oshino N, Chance B, Sies H, Bucher T. The role of H2O2 generation in 
perfused rat liver and the reaction of catalase compound I and 
hydrogen donors. Arch. Biochem. Biophys. 1973. 154: 117–131 
154. Paolicchi A, Dominici S, Pieri L, Maellaro E, Pompella A. Glutathione 
catabolism as a signaling mechanism. Biochem. Pharmacol 2002.  64: 
1027–1035 
155. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, 
and Yang CSCytochrome P450 enzymes involved in acetaminophen 
activation by rat and human liver microsomes and their kinetics. Chem 
Res Toxicol 1993. 6:511–518 
156. Pena MM, Lee J, Thiele DJ. A delicate balance: homeostatic control of 
copper uptake and distribution. J Nutr 1999. 129:1251–1260 
157. Pinsent J. The need for selenite and molybdate in the formation of 
formic dehydrogenase by members of the Colaerogenes group of 
bacteria. Biochem J  1954. 57:10-16 
158. Prescott LF  Hepatotoxicity of mild analgesics Br J Clin Pharmacol 
1980. 10:373S–379S 
159. Prohaska JR. Changes in Cu,Zn-superoxide dismutase, cytochrome c 
oxidase, glutathione peroxidase and glutathione transferase activities in 
copper-deficient mice and rats. J Nutr 1991. 121:355–363 
160. Pryor WA, Squadrito GL.  The chemistry of peroxynitrite: a product from 
the reaction of nitric oxide with superoxide. Am J Physiol. 1995. 
268:L699-722 
161. Pushpa-Rekha TR, Burdsall AL, Oleksa LM, Chisolm GM, Driscoll D M. 
Rat phospholipid-hydroperoxide glutathione peroxidase. cDNA cloning 
and identification of multiple transcription and translation start sites. J 
Biol Chem 1995. 270:26993–26999 
 88
162. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O’Halloran TV. 
Undetectable intracellular free copper: the requirement of a copper 
chaperone for superoxide dismutase. Science 1999. 284:805–808 
163. Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ 2nd, Herman B, 
Richardson A, Van Remmen H. Transgenic mice overexpressing 
glutathione peroxidase 4 are protected against oxidative stress-induced 
apoptosis. J Biol Chem  2004. 279:55137-55146  
164. Ran Q, Van Remmen H, Gu M, Qi W, Roberts LJ 2nd, Prolla T, 
Richardson A. Embryonic fibroblasts from GPx4+/- mice: a novel model 
for studying the role of membrane peroxidation in biological processes. 
Free Radic Biol Med 2003. 35:1101-1109  
165. Read R, Bellew T, Yang JG, Hill KE, Palmer IS, Burk RF.  Selenium 
and amino acid composition of selenoprotein P, the major selenoprotein 
in rat serum. J Biol Chem. 1990. 265:17899-17905 
166. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek 
DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider 
WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice 
develop normally but exhibit enhanced cell death after axonal injury. 
Nat Genet 1996. 3:43–47  
167. Reznick A, Packer L. Oxidative damage to proteins: spectrophotometric 
method for carbonyl assay. Methods Enzymol 1994. 233:357-363  
168. Rhee SG. Redox signaling: hydrogen peroxide as intracellular 
messenger. Exp Mol Med 1999. 1:53–59 
169. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, 
Donaldson D, Goto, J, O’Regan JP, Deng H-X, Rahmani Z, Krizus A, 
McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, 
Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, 
Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines 
J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr. Mutations in 
Cu/Zn superoxide dismutase gene are associated with familial 
amyotrophic lateral sclerosis. Nature 1993.362:59–62  
170. Rosenthal P. Assessing liver function and hyperbilirubinemia in the 
newborn. Clin Chem. 1997. 43:228-234 
 89
171. Rotruck JT, Pope AL, Ganther HE, Hoekstra WG.  Prevention of 
oxidative damage to rat erythrocytes by dietary selenium. J Nutr. 1972. 
102:689-696 
172. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, 
Hoekstra WG. Selenium: biochemical role as a component of 
glutathione peroxidase. Science 1973. 179: 588–590 
173. Roveri A, Casasco A, Maiorino M, Dalan P, Calligaro A, Ursini F. 
Phospholipid hydroperoxide glutathione peroxidase of rat testis. 
Gonadotropin dependence and immunocytochemical identification. J 
Biol Chem 1992. 267:6142-6146  
174. Saito Y, Hayashi T, Tanaka A, Watanabe Y, Suzuki M, Saito E, 
Takahashi K. Selenoprotein P in human plasma as an extracellular 
phospholipid hydroperoxide glutathione peroxidase. Isolation and 
enzymatic characterization of human selenoprotein P. J Biol Chem. 
1999 274:2866-2871 
175. Salvatore D, Low SC, Berry M, Maia AL, Harney JW, Croteau W, St 
Germain DL, Larsen PR.  Type 3 Iodothyronine deiodinase: cloning, in 
vitro expression, and functional analysis of the placental selenoenzyme. 
J Clin Invest. 1995 . 96:2421-2430 
176. Sauer B. Inducible gene targeting in mice using the Cre/lox system. 
Methods. 1998 14:381-392 
177. Schnurr K, Belkner J, Ursini F, Schewe T, Kuhn H.  The selenoenzyme 
phospholipid hydroperoxide glutathione peroxidase controls the activity 
of the 15-lipoxygenase with complex substrates and preserves the 
specificity of the oxygenation products. J Biol Chem 1996. 271:4653-
4658  
178. Schuckelt R, Brigelius-Flohe R, Maiorino M, Roveri A, Reumkens J, 
Strassburger W, Ursini F, Wolf B, Flohe L.   Phospholipid hydroperoxide 
glutathione peroxidase is a selenoenzyme distinct from the classical 
glutathione peroxidase as evident from cDNA and amino acid 
sequencing. Free Radic Res Commun 1991. 14:343-361  
179. Schwarz K, Foltz TM. Selenium as an integral part of factor 3 against 
dietary liver degeneration. J Am Chem Soc 1957. 79:3292–3293 
 90
180. Scott ML.  Advances in our understanding of vitamin E. Fed Proc. 1980. 
39:2736-2739 
181. Shen Y, Sangiah S.  Na+, K(+)-ATPase, glutathione, and hydroxyl free 
radicals in cadmium chloride-induced testicular toxicity in mice. Arch 
Environ Contam Toxicol 1995. 29:174-179 
182. Shim H, Harris ZL. Genetic defects in copper metabolism. J Nutr 2003. 
133:1527S–1531S 
183. Sies H, Sharov VS, Klotz LO, Briviba K.  Glutathione peroxidase 
protects against peroxynitrite-mediated oxidations. Anew function for 
selenoproteins as peroxynitrite reductase. J Biol Chem. 1997. 
272:27812-27817 
184. Smith CV, Hughes H, Lauterburg BH, Mitchell JR. Oxidant stress and 
hepatic necrosis in rats treated with diquat. J Pharmacol Exp Ther. 
1985. 235:172-177. 
185. Smith CV.  Effect of BCNU pretreatment on diquat-induced oxidant 
stress and hepatotoxicity. Biochem Biophys Res Commun. 1987a. 
144:415-421 
186. Smith CV.   Evidence for participation of lipid peroxidation and iron in 
diquat-induced hepatic necrosis in vivo. Mol Pharmacol. 1987b. 32:417-
422 
187. Smith LL.  Mechanism of paraquat toxicity in lung and its relevance to 
treatment. Hum Toxicol. 1987c. 6:31-36 
188. Spaulding DJM, Mitchell JR, Jaeschke H, Smith CV. Diquat 
hepatotoxicity in the Fischer-344 rat: The role of covalent binding to 
tissue proteins and lipids. Toxcol Appl Pharmacol 1989. 101: 319-327 
189. Stadtman ER, Levine RL.Free radical-mediated oxidation of free amino 
acids and amino acid residues in proteins Amino Acids 2003. 25: 207–
218 
190. Stadtman TC.  Selenocysteine. Annu Rev Biochem. 1996. 65:83-100 
 91
191. Stadtman TC. Selenium biochemistry. Mammalian selenoenzymes. Ann 
NY Acad Sci 2000. 899:399–402 
192. Stadtman TC. Bacterial selenoenzymes and mechanisms of action. pp. 
115–122 In: Hatfield DL, ed. Selenium. Its Molecular Biology and Role 
in Human Health. Kluwer. Boston, MA 2001 
193. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione- S-
transferase family of enzymes. Mutat. Res. 2001. 482: 21–26 
194. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, 
Gladyshev VN. Redox regulation of cell signaling by selenocysteine in 
mammalian thioredoxin reductases. J Biol Chem. 1999. 274:24522-
24530 
195. Sunde RA. 2001. Regulation of selenoprotein expression. pp. 81–98 In: 
Hatfield DL, ed.  Selenium. Its Molecular Biology and Role in Human 
Health. Kluwer. Boston, MA 2001 
196. Sunde, RA.  Intracellular glutathione peroxidase - structures, regulation 
and functions. In: Burk, RF., Ed pp. 45-77  Selenium in Biology and 
Human Health. Springer-Verlag, New York, NY. 1994 
197. Takahashi K, Akasaka M, Yamamoto Y, Kobayashi C, Mizoguchi J, 
Koyama J.  Primary structure of human plasma glutathione peroxidase 
deduced from cDNA sequences. J Biochem (Tokyo). 1990. 108:145-
148  
198. Takahashi K, Cohen HJ.  Selenium-dependent glutathione peroxidase 
protein and activity: immunological investigations on cellular and 
plasma enzymes. Blood. 1986. 68:640-645  
199. Tamura T, Stadtman TC.  A new selenoprotein from human lung 
adenocarcinoma cells: purification, properties, and thioredoxin 
reductase activity. Proc Natl Acad Sci U S A. 1996. 93:1006-1011 
200. Tham DM, Whitin JC, Kim KK, Zhu SX, Cohen HJ.  Expression of 
extracellular glutathione peroxidase in human and mouse 
gastrointestinal tract. Am J Physiol. 1998. 275:G1463-G1471 
 92
201. Thannickal, V. J, Fanburg, B. L. Reactive oxygen species in cell 
signaling. Am J Physiol Lung Cell Mol Physiol 2000. 279:L1005– L1028  
202. Thompson JN, Scott ML. Role of selenium in the nutrition of the chick. J 
Nutr 1969. 97: 335-342 
203. Thompson KM, Haibach H, Evenson JK, Sunde RA. Liver selenium and 
testis phospholipid hydroperoxide glutathione peroxidase are 
associated with growth during selenium repletion of second-generation 
Se-deficient male rats. J Nutr 1998.128:1289-1295 
204. Thummel KE, Lee CA, Kunze KL, Nelson SD, and Slattery JT Oxidation 
of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human 
CYP3A4. Biochem Pharmacol  1993. 45:1563–1569 
205. Turnlund JR, Scott KC, Peiffer GL, Jang AM, Keyes WR, Keen CL, 
Sakanashi TM. Copper status of young men consuming a low-copper 
diet. Am J Clin Nutr 1997. 65:72–78 
206. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, Flohe L.  
Dual function of the selenoprotein PHGPx during sperm maturation. 
Science 1999. 285:1393-1396 
207. Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid 
hydroperoxide glutathione peroxidase. Biochim Biophys Acta 1985. 
839:62-70  
208. Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C. Purification from 
pig liver of a protein which protects liposomes and biomembranes from 
peroxidative degradation and exhibits glutathione peroxidase activity on 
phosphatidylcholine hydroperoxides. Biochim Biophys Acta 1982. 
710:197-211 
209. Utsunomiya H, Komatsu N, Yoshimura S, Tsutsumi Y, Watanabe K. 
Exact ultrastructural localization of glutathione peroxidase in normal rat 
hepatocytes: advantages of microwave fixation. J Histochem Cytochem 
1991. 39:1167– 1174 
 93
210. Vendeland SC, Beilstein MA, Chen CL, Jensen ON, Barofsky E, 
Whanger PD.  Purification and properties of selenoprotein W from rat 
muscle. J Biol Chem. 1993. 268:17103-17107 
211. Vendeland SC, Beilstein MA, Yeh JY, Ream W, Whanger PD.  Rat 
skeletal muscle selenoprotein W: cDNA clone and mRNA modulation 
by dietary selenium. Proc Natl Acad Sci U S A. 1995. 92:8749-8753 
212. Wang HP, Qian SY, Schafer FQ, Domann FE, Oberley LW, Buettner 
GR.  Phospholipid hydroperoxide glutathione peroxidase protects 
against singlet oxygen-induced cell damage of photodynamic therapy. 
Free Radic Biol Med   2001. 30:825-835 
213. Weisiger RA, Fridovich I. Mitochondrial superoxide dismutase: site of 
synthesis and intramitochondrial localization. J Biol Chem 1973. 
248:4793–4796  
214. Weitzel F, Ursini F, Wendel A.  Phospholipid hydroperoxide glutathione 
peroxidase in various mouse organs during selenium deficiency and 
repletion. Biochim Biophys Acta 1990. 1036:88-94 
215. Weitzel F, Wendel A.  Selenoenzymes regulate the activity of leukocyte 
5-lipoxygenase via the peroxide tone. J Biol Chem 1993. 268:6288-
6292  
216. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, 
Valentine JS, Bredesen, DE. Altered reactivity of superoxide dismutase 
in familial amyotrophic lateral sclerosis. Science 1996. 271:515–551 
217. Wingler, K, Bocher, M, Flohe, L, Kollmus, H, Brigelius-Flohe, R. mRNA 
stability and selenocysteine insertion sequence efficiency rank 
gastrointestinal glutathione peroxidase high in the hierarchy of 
selenoproteins. Eur J Biochem. 1999. 259:149–157  
 
218. Winter ML, Liehr JG. Free radical-induced carbonyl content in protein of 
estrogen-treated hamsters assayed by sodium boro[3H]hydride 
reduction. J Biol Chem 1991. 266:14446-14450  
 94
219. Witschi H, Kacew S, Hirai K-I, Cote MG. In vivo oxidation of reduced 
nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in 
rat lung. Chem Biol Interact 1977. 19:143–160 
220. YamamotoY, Takahashi K. Glutathione peroxidase isolated from 
plasma reduces phospholipid hydroperoxides. Arch Biochem Biophys 
1993. 305:541– 545  
221. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta 
L, Richardson A, Prolla TA.  The selenoprotein GPX4 is essential for 
mouse development and protects from radiation and oxidative damage 
insults. Free Radic Biol Med. 2003.34:496-502  
222. Yoshida T, Maulik N, Engelman RM, Ho Y-S, Das DK. Targeted 
disruption of the mouse Sod1 gene makes the hearts vulnerable to 
ischemic reperfusion injury. Circ Res 2000. 86:264–269 
223. Yoshimura S, Suemizu H, Taniguchi Y, Arimori K, Kawabe N, Moriuchi 
T. The human plasma glutathione peroxidase-encoding gene: 
organization, sequence and localization to chromosome 5q32.Gene. 
1994. 145:293-297  
224. Yoshimura S, Watanabe K, Suemizu H, Onozawa T, Mizoguchi J, 
Tsuda K, Hatta H, Moriuchi T.  Tissue specific expression of the plasma 
glutathione peroxidase gene in rat kidney. J Biochem (Tokyo). 1991. 
109:918-923 
225. Zhang J, Graham DG, Montine TJ, Ho Y-S. Enhanced N-methyl-4- 
phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in copper 
zinc superoxide dismutase or glutathione peroxidase. J Neuropathol 
Exp Neurol 2000. 59:53–61 
